A NOVEL APPROACH TO THE TREATMENT OF CAUDAL HEEL PAIN USING EXTRACORPOREAL SHOCK WAVE THERAPY by MacKay, Angela 1989-
A NOVEL APPROACH TO THE TREATMENT OF CAUDAL HEEL PAIN USING 
EXTRACORPOREAL SHOCK WAVE THERAPY 
 
A Thesis Submitted to the College of 
Graduate and Postdoctoral Studies 
In Partial Fulfillment of the Requirements 
For the Degree of Master of Science 
In the Department of Large Animal Clinical Sciences 
University of Saskatchewan 
Saskatoon 
 
By 
 
Angela Vivien MacKay 
 
Copyright Angela MacKay, 2019. All rights reserved. 
 
 
 
 
 
 
 i 
PERMISSION TO USE 
 
In presenting this thesis in partial fulfilment of the requirements for a Postgraduate degree from the 
University of Saskatchewan, I agree that the Libraries of this University may make it freely 
available for inspection. I further agree that permission for copying of this thesis in any manner, in 
whole or in part, for scholarly purposes may be granted by the professor or professors who 
supervised my thesis work or, in their absence, by the Head of the Department or the Dean of the 
College in which my thesis work was done. It is understood that any copying or publication or use 
of this thesis or parts thereof for financial gain shall not be allowed without my written permission. 
It is also understood that due recognition shall be given to me and to the University of 
Saskatchewan in any scholarly use which may be made of any material in my thesis. 
 
Requests for permission to copy or to make other use of material in this thesis in whole or part 
should be addressed to: 
 
Head of the Department of Large Animal Clinical Sciences 
University of Saskatchewan 
52 Campus Drive, Saskatoon, Saskatchewan S7N 5B4 
 
Or 
 
Dean of College of Graduate and Postdoctoral Studies 
University of Saskatchewan 
116 Thorvaldson Building, 110 Science Place, Saskatoon, Saskatchewan S7N 5C 
 
 
 
 
 
 
 
 ii 
ABSTRACT 
 
 Anecdotally, extracorporeal shock wave therapy (ESWT) is widely used in equine 
practice to treat a variety of musculoskeletal conditions.  The therapy has been used to treat 
caudal heel pain of the forelimbs, a common, chronic, degenerative condition that causes 
lameness. The objectives of this study were to characterize the use of ESWT among equine 
practitioners in North America, and following this, to determine the analgesic efficacy of focused 
ESWT on horses with naturally occurring caudal heel pain and the effect of this therapy on the 
appearance of lesions diagnosed by magnetic resonance imaging (MRI) in the same group of 
horses. A 21-question online survey was conducted to evaluate equine practitioners' rate of use, 
indication for use, and opinion of efficacy and tolerability of ESWT for their equine patients. 
ESWT was used frequently by 65/144 (45.1%) respondents, infrequently by 61/144 (42.4%) 
respondents, and never by 18/144 (12.5%) respondents. The most common reason for use was to 
treat ligamentous injuries. Overall, the therapy was rated as a moderately effective option for 
various musculoskeletal conditions of the horse.  
 In the second experiment, 49 limbs (11 unilateral, 19 bilateral; 30 horses total) were 
examined using subjective lameness evaluation, kinematic gait analysis, and MRI. Following 
randomization, fifteen horses with naturally occurring caudal heel pain were treated with focused 
ESWT under standing sedation, and fifteen horses received no treatment but standing sedation. 
Outcome measures included change in subjective lameness grade of each limb, total lameness 
score of each horse, absolute change in kinematic gait analysis measures, and change in MRI 
grades for each included limb from day -16 to day 128. The results indicated that focused ESWT 
decreased subjectively assessed pain in horses with unilateral caudal heel pain for at least 128 
days (p=0.049). No significant differences were noted in kinematic gait analysis variables 
between groups. Horses treated with ESWT experienced a worsening of navicular bursitis 
(p=0.027). In summary, based on the response to treatment with ESWT, we are unable to firmly 
recommend the therapy for horses with caudal heel pain at this time. Some horses may 
experience analgesia that may not be related to improvement of the lesions within the foot.   
 Key words: Extracorporeal shock wave therapy, Caudal heel pain, Equine, Magnetic 
resonance imaging 
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1.  GENERAL INTRODUCTION 
 
 The use of new technological procedures in equine practice has advanced at a pace faster 
than the scientific investigation and validation of the efficacy of these procedures. Multiple 
treatment options are available for musculoskeletal injuries that are not supported by blinded, 
controlled, peer-reviewed studies. Horse owners are often aware of these different treatments and 
request them for their animals. The burden is placed on the veterinarian to decipher any available 
research in order to be able to confidently recommend or discourage the use of a particular 
treatment for certain conditions. Such treatments include but are not limited to: extracorporeal 
shock wave therapy (ESWT), low level laser therapy, pulsed electromagnetic field therapy, and 
certain drugs such as bisphosphonates. Many of these treatments have been used with frequency 
in either the human medical field or small animal veterinary medical field prior to introduction 
into equine clinical practice. ESWT is one such therapy, with origins in human medicine to 
dissolve urinary and renal calculi (Chung and Wiley, 2002; McClure and Dorfmüller, 2003).  
 ESWT is available in both focused and non-focused (radial/ballistic) forms. This therapy 
involves the use of a machine that generates a pressure wave that can be directed at a target tissue 
or body part. This pressure wave causes cell displacement without heating and can stimulate a 
change in the release or production of multiple growth factors, depending on the target tissue 
(Chung and Wiley, 2002). Prior research in laboratory animals and humans has suggested that 
ESWT may improve osseous unions at the site of chronic fractures (Schaden et al., 2001; F. S. 
Wang et al., 2002), may stimulate an increased quality of healing in soft tissues (F. S. Wang et 
al., 2002), and can reduce pain and improve quality of life when used to treat chronic 
degenerative conditions (Chen et al., 2014; Chow and Cheing, 2007; Mani-Babu et al., 2015).  
 In horses, ESWT is anecdotally used for a wide variety of musculoskeletal conditions. 
The true prevalence of and indication for use by equine veterinarians is unknown. Commercially 
available ESWT units for veterinarians may provide protocols for use with tendinitis, desmitis, 
osteoarthritis, epaxial muscle pain, wounds, and caudal heel pain. Research in a wide variety of 
conditions in the horse has been unable to determine a clear mechanism of action but some 
clinical benefit when compared to negative controls (Caminoto et al., 2005; Frisbie et al., 2009; 
Kawcak et al., 2011; McClure and Dorfmüller, 2003; Waguespack et al., 2011).  
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 Caudal heel pain is a common cause of chronic forelimb lameness in the horse (Sampson 
et al., 2009). The disease is best diagnosed with the use of advanced diagnostic imaging, such as 
magnetic resonance imaging (MRI) (Dyson et al., 2011a). Treatment options include therapeutic 
farrier work, systemic anti-inflammatories, intra-articular or intra-bursal medication, systemic 
bisphosphonates, and vasoactive medications (Barrett et al., 2017; Bell et al., 2009; Denoix et al., 
2003; Schoonover et al., 2005). ESWT has been shown to be effective at reducing pain and 
lameness associated with the condition, although prior work has lacked comparison to a control 
group (Dahlberg et al., 2006; McClure et al., 2004a).  
 Given the frequency with which caudal heel pain is diagnosed in horses, and the lack of 
scientific evidence supporting ESWT as a treatment option, it is important to explore the use of 
this therapy in horses. Knowledge regarding the general use of ESWT across equine 
musculoskeletal diseases is useful for helping equine veterinarians make informed decisions 
about their treatment protocols. Likewise, scientific evidence for or against the use of ESWT as a 
treatment for caudal heel pain will help veterinarians make logical recommendations when 
treating their patients. The following discussion will review caudal heel pain (pathology, 
diagnosis and treatment) in detail, and ESWT as it pertains to musculoskeletal conditions in the 
horse.  
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2.1   Anatomy and Physiology of the Equine Podotrochlear Apparatus 
 
2.1.1   Gross anatomy of the podotrochlear apparatus and relations with other 
structures in the foot 
 The podotrochlear apparatus (PTA) of the equine foot is comprised of the navicular bone, 
the navicular bursa, the collateral sesamoidean ligaments (CSL), the distal sesamoidean impar 
ligament (DSIL), and the distal portion of the deep digital flexor tendon (DDFT) (Busoni and 
Denoix, 2001; Dyson et al., 2011a) (Figure 2.1). The navicular bone is the distal sesamoid bone 
for the DDFT at the angle of insertion, and is the central structure of the PTA (Gabriel et al., 
1998). This small oblong bone lies palmar/plantar to the distal phalanx and palmaro/plantaro-
distal to the middle phalanx, and articulates with both bones to form the distal interphalangeal 
joint (Kainer and Fails, 2011). The remainder of this discussion will focus on the navicular bone 
and PTA in the forelimb only. The navicular bone has four borders or cortices: the proximal 
cortex, the articular or dorsal cortex which has a hyaline cartilage surface as per its articulation, 
the palmar or flexor cortex, which has a fibrocartilage surface, and the distal cortex, part of which 
articulates with the distal phalanx (Gabriel et al., 1998; Wright et al., 1998). The CSL and DSIL 
make up the navicular suspensory apparatus to suspend the navicular bone in place (Kainer and 
Fails, 2011). The CSL extend from the distal aspect of the proximal phalanx and the middle 
phalanx to insert on the proximal border of the navicular bone and connect the bone to the lateral 
and medial collateral cartilages of the distal phalanx, providing proximal and medial-lateral 
support for the navicular bone (Gabriel et al., 1998; Van Wulfen and Bowker, 1997). The DSIL 
stabilizes the navicular bone distally by extending from the distal border to insert on the palmar 
aspect of the distal phalanx, dorsal to the insertion of the DDFT (Kainer and Fails, 2011). The 
DDFT courses palmar to and against the flexor surface of the navicular bone over the navicular 
bursa to insert on the palmar aspect of the distal phalanx (Dyson et al., 2003).  
 Other pertinent structures within the foot that are closely associated with the PTA include 
the distal interphalangeal joint, the collateral ligaments of the distal interphalangeal joint, the 
palmar processes of the distal phalanx, the digital cushion, the distal digital annular ligament, and 
the ligaments of the collateral cartilages of the distal phalanx (Bowker et al., 1997; Dabareiner 
and Carter, 2003; Kainer and Fails, 2011) (Figure 2.1).  
 
 5 
Figure 2.1 Anatomical section of the equine podotrochlear apparatus and associated structures;  
1: Navicular bone, 1a: Navicular bone flexor surface fibrocartilage, 2: Distal phalanx, 3: Distal 
sesamoidean impar ligament, 4: Navicular bursa, 5: Deep digital flexor tendon, 6: Collateral 
sesamoidean ligaments, 7: Digital cushion, 8: Distal interphalangeal joint, 9: Middle phalanx.  
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2.1.2   Histological anatomy of the podotrochlear apparatus 
 Histological anatomy of the PTA has been shown to correlate with anatomy identified on 
magnetic resonance imaging (MRI) (Murray et al., 2006a), so deviations from normal are 
important to understand. Hyaline cartilage lines the dorsal cortex and the dorsal aspect of the 
distal cortex of the navicular bone (Blunden et al., 2006a). The flexor cortex of the navicular 
bone is covered in fibrocartilage (Gabriel et al., 1998). This aspect of the navicular bone is under 
a high degree of compressive strain, and the trabecular alignment within the bone is oriented 
along the axis of the compressive forces that arise from the DDFT (Wilson et al., 2001).  
 Nutrient foramina are present in the distal cortex of the navicular bone. Distal nutrient 
foramina contain blood vessels and vary in width, but this is not related to pathology of the 
vasculature (Wright et al., 1998). Synovial invaginations are present primarily in the distal cortex 
of the navicular bone, but also in the proximal, medial and lateral cortices, and are lined with 
synovium (Claerhoudt et al., 2011). Olive and Videau (2017) recently determined that distal 
border synovial invaginations of the navicular bone communicate with the distal interphalangeal 
joint, but not with the navicular bursa. 
 The DSIL originates from the distal cortex of the navicular bone, and has linear fibers 
running in fascicles between the navicular bone and the distal phalanx. The interstitium between 
the fascicles is well vascularized and has pockets that are lined with synovial membrane. Both the 
origin and insertion of the DSIL represent a bone-ligament interface (Blunden et al., 2006a). The 
insertions of the DSIL and the DDFT have large numbers of sensory nerve endings and 
arteriovenous complexes (Van Wulfen and Bowker, 1997). Smooth transitional fibrocartilaginous 
metaplasia may be present at the edges of the CSL (Blunden et al., 2006a).  
 
2.1.3   Physiology and function of the podotrochlear apparatus 
 The PTA provides palmar stability for the distal interphalangeal joint (Dyson et al., 
2011a; Parkes et al., 2015) and resists hyperextension of the distal interphalangeal joint at the 
break-over point of the stride (Murray et al., 2006b). The navicular bone provides a constant 
angle of insertion to maintain mechanical advantage for the DDFT, and acts as a fulcrum to allow 
for flexion of the distal interphalangeal joint (Dyson et al., 2011a; Kainer and Fails, 2011). The 
distal third of the navicular bone experiences strong compressive forces both during the 
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propulsion and the stance phase of the stride as a result of the change in angle of the DDFT 
(Dyson et al., 2011a; Wilson et al., 2001).  
 The function and biomechanics of the PTA inherently lead to adaptive changes within the 
structures of the apparatus (Wright et al., 1998). The navicular bone experiences both tension 
from the suspensory apparatus and compressive forces from the DDFT during stance and 
propulsion during a stride (Bowker et al., 2001; Wilson et al., 2001). The flexor cortex may 
thicken due to increased tension within the CSL and DSIL as a result of increased exercise (Biggi 
and Dyson, 2012). A zone of fibrocartilage may form in the dorsal aspect of the DDFT 
immediately proximal to the navicular bone that is rich in elastic fibers (Blunden et al., 2006b). 
This is thought to represent a functional adaptation similar to the superficial digital flexor tendon 
at the palmar fetlock region, where the tendon experiences higher compressive force (Blunden et 
al., 2006b; Smith et al., 1997).   
 The function of the navicular bone and PTA may contribute to the development of caudal 
heel pain if the normal forces on the bone become altered due to external factors (McGuigan and 
Wilson, 2001; Wilson et al., 2001). The entire foot of the horse plays a part in maintaining 
normal physiology and therefore normal forces on the PTA. Key structures include the blood 
supply and the digital cushion. 
 
2.1.3.1   Blood supply 
 The equine foot, including the PTA, is supplied by an extensive system of connected and 
anastomosing vessels (Rijkenhuizen et al., 1989a). The arterial supply of the foot arises from 
branches of the medial and lateral digital arteries, the dorsal artery of the middle phalanx, the 
palmar artery of the middle phalanx, and the dorsal artery of the distal phalanx. The navicular 
bone is supplied primarily by the branches of the medial and lateral digital arteries branching to 
enter the distal border, and the palmar artery of the middle phalanx that forms branches and 
anastomoses to enter the proximal border (Rijkenhuizen et al., 1989a). Venous drainage exits the 
navicular bone at the distal border through the DSIL to the solar venous plexus, which then forms 
the medial and lateral digital vein. Further venous branches exit the navicular bone from the 
proximal border to form anastomoses with the medial and lateral digital veins (Rijkenhuizen et 
al., 1989b, 1989a). Most veins in the foot do not have valves, so blood flow from the foot can 
take different routes through the various anastomoses. Normal weight bearing and movement is 
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critical to ensure proximal flow of blood with the assistance of the digital cushion (Bowker, 
2003; Gunkelman and Hammer, 2017; Rijkenhuizen et al., 1989b, 1989a).  
 
2.1.3.2   Digital Cushion 
 The digital cushion is located between the collateral cartilages of the foot and above the 
frog. This cushioning structure is made up of collagen, elastic fibers, fibrocartilage and adipose 
tissue (Bowker, 2003; Gunkelman and Hammer, 2017). The digital cushion is important for 
shock absorption during impact with the ground and may assist with blood pumping to encourage 
venous return in a proximal direction (Bowker, 2003; Bowker et al., 1998). The composition of 
the digital cushion changes with age from fat and elastic tissue to stronger fibrocartilage. Poor 
foot conformation may result in altered stride biomechanics and decreased compression of the 
digital cushion, consequently resulting in decreased shock absorption and blood flow efficiency, 
and a higher percent of impact being transferred to the bony column of the limb (Bowker, 2003). 
 
2.2   Caudal Heel Pain (Navicular Syndrome) 
 
2.2.1   Definition of caudal heel pain and other terms used  
 Caudal heel pain is defined as lameness resulting from pain associated with pathology of 
the navicular bone, with or without injury affecting the soft tissue structures of the PTA (Parkes 
et al., 2015). Other terms used to describe this syndrome include palmar heel pain, palmar foot 
pain, podotrochlosis, navicular syndrome, or navicular disease (Dyson et al., 2011a; Groth et al., 
2009; Maher et al., 2011; Marsh et al., 2012; Murray et al., 2006b; Parkes et al., 2015; Sherlock 
et al., 2008). The term “navicular disease” has historically referred to pain originating from the 
navicular bone of the forelimbs (Baxter et al., 2011). However, pathology of the navicular bone 
in isolation is a rare occurrence (Dyson et al., 2012) and advances in diagnostic imaging 
technology have identified injury to both the osseous and the soft tissue structures of the PTA 
(Dyson et al., 2011a; Parkes et al., 2015). A diagnosis of caudal heel pain now describes a 
clinical syndrome representing a multitude of pathologic lesions within the PTA. This is 
important to understand when considering rational diagnostic and treatment options (Murray et 
al., 2006b). Reports of caudal heel pain in the hindlimbs are rare, so the syndrome is typically 
considered a forelimb problem (Dyson et al., 2011a). 
 9 
 
2.2.2   Epidemiology of caudal heel pain 
 Large scale epidemiologic descriptions of caudal heel pain are not available (Dyson et al., 
2011a). The true prevalence has not been established, but the syndrome is estimated to cause one 
third of all forelimb lameness in horses (Dabareiner and Carter, 2003; Sampson et al., 2009). 
Retrospective reports of cohorts of affected horses indicate that there is a high incidence in the 
Quarter Horse, Warmblood, and Thoroughbred cross breeds (Bell et al., 2009; Biggi and Dyson, 
2011; Gutierrez-Nibeyro et al., 2012; Sampson et al., 2009). A genetic predisposition has been 
identified in Dutch Warmblood and Hanoverian breeds, primarily associated with navicular bone 
proximal border shape (Dik et al., 2001a, 2001b; Dik and van den Broek, 1995). No such 
heritability has been established in other breeds of horses.  
 Risk factors for syndrome development have been difficult to quantify, but it has been 
reported in the United Kingdom and Europe that horses with long toes and low heels may be 
predisposed to caudal heel pain (Dyson et al., 2011a). In North America, horses with 
proportionally small feet for their body size with upright foot conformation may be more 
predisposed. In addition, poor musculoskeletal conformation, poor farrier and hoof care, exercise 
on hard surfaces, and abnormal stresses placed on the foot such as tight turns at speed or landing 
following a jump may all predispose a horse to the development of caudal heel pain (Dabareiner 
and Carter, 2003). 
 
2.2.3   Pathologic lesions consistent with caudal heel pain 
 A complex of degenerative changes is commonly noted in the PTA of horses affected 
with caudal heel pain, including abnormalities of the CSL, DSIL, and the navicular bursa, in 
conjunction with DDFT and navicular bone lesions (Dyson et al., 2012, 2011a, 2003; Dyson and 
Murray, 2007a). Pathology of the navicular bone in isolation is rarely identified, and usually 
cases of caudal heel pain involve injury to two or more structures of the PTA (Dyson et al., 2012; 
Murray et al., 2006b). Retrospective studies support this finding. Gutierrez-Nibeyro et al. (2010) 
evaluated 56 horses with pain localized to the palmar heel region; 50/56 horses had multiple 
abnormalities in closely related structures in the lamest limb, and 38% of that population had 
concurrent injury to the DDFT, navicular bursa, and navicular bone. Murray et al. (2006b) had 
similar results. It is important to note that primary injury to the DDFT within the foot in the 
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absence of abnormalities of the other podotrochlear structures is not considered caudal heel pain 
per se, but may be a precursor to the syndrome (Dyson et al., 2011a, 2003).  
 With the advent of MRI, accurate ante-mortem lesion identification, classification, and 
grading in comparison to histologic findings has been made possible. Prior to MRI, soft tissue 
injury would only have been suspected in horses with lameness localized to the caudal heel 
region of the front foot and no radiographic abnormalities. Now, these cases of caudal heel pain 
can be further characterized using MRI, and a range of lesions have been identified (Sampson et 
al., 2009). Early disease may present as navicular bone edema and dorsal fibrillation of the DDFT 
identified on MRI (Dyson et al., 2011a; Sampson et al., 2009), whereas advanced cases of caudal 
heel pain often involve navicular bone degeneration combined with fibrillation of the dorsal 
aspect of the DDFT and sometimes adhesion formation between the tendon and the navicular 
bursa and/or navicular bone (Wright et al., 1998). While usually considered in concert, each 
structure of the PTA can have a range of abnormalities that have been confirmed histologically.  
 
2.2.3.1   Navicular bone 
 Numerous abnormalities of the navicular bone have been described. Erosive lesions 
through the fibrocartilage or extending into the subchondral bone may be present on the flexor 
cortex (Sherlock et al., 2008; Wright et al., 1998). This may represent irreversible damage. These 
severe cases of caudal heel pain will have histologic abnormalities consistent with fibrocartilage 
degeneration and subchondral bone necrosis with possible areas of fibrosis and sclerosis 
(Blunden et al., 2006a). In addition, concurrent degenerative lesions of the navicular bone 
medulla may be present.  These may include lysis of the subchondral bone adjacent to the 
fibrocartilage defects as well as congestion, fibrosis, and bone loss within the medulla. Less 
advanced cases of caudal heel pain may have histopathologic findings such as thinning, 
fibrillation or loss of the fibrocartilage layer, including in areas with no gross pathologic evidence 
of fibrocartilage erosion (Blunden et al., 2006a; Dyson et al., 2012; Wright et al., 1998). 
Corresponding abnormalities within the subchondral bone may be noted as regions of thinned or 
lost bone being replaced by fibrovascular tissue (Sherlock et al., 2008). 
  In addition to degeneration of the flexor cortex, the distal and proximal borders of the 
navicular bone may also exhibit pathology. Distal border fragments are associated with caudal 
heel pain, but have also been observed in non-lame limbs (Biggi and Dyson, 2012). 
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Entheseophytes may develop in association with the attachments of the DSIL and CSL on the 
distal and proximal cortices, respectively (Blunden et al., 2006a; Murray et al., 2006b). Synovial 
invaginations on the distal aspect of the navicular bone may be enlarged, although the 
significance of this finding in cases of caudal heel pain is debated. This is due to the fact that 
these invaginations have been shown to communicate only with the distal interphalangeal joint, 
and not with the navicular bursa (Olive and Videau, 2017). However, chronic inflammation of the 
distal interphalangeal joint could contribute to local osteonecrosis of the navicular bone (Dyson 
and Murray, 2007a), and inflammation of the distal interphalangeal joint may occur in 
conjunction with injury to the PTA (Blunden et al., 2006a; Sampson et al., 2009). Osseous cyst-
like lesions may be present in the navicular bone medulla, and are typically pseudocysts with a 
fibrous capsule upon histologic examination (Wright et al., 1998). These lytic defects can be 
associated with areas of thinned fibrocartilage on the flexor cortex, and some may even 
communicate with a cortical bone defect, although another study has observed osseous cyst-like 
lesions in association with distal border fragments (Biggi and Dyson, 2010). Navicular bone 
medullary changes may also include sclerosis, which is often adjacent to palmar cortex 
fibrocartilage erosion (Pool et al., 1989).  
 Some cases of caudal heel pain may have increased MRI signal within the navicular bone 
medulla on fat suppressed images as the only abnormal finding. This may represent diffuse 
abnormalities such as osseous edema, contusion, osteonecrosis, capillary infiltration, or 
hemorrhage, which can only be definitively determined with post-mortem histologic evaluation 
(Busoni et al., 2005; Murray et al., 2006a). Pathologic change in the navicular bone has been 
identified as having a symmetrical distribution with some evidence of a pattern, likely related to 
the compressive forces the bone experiences from the DDFT (Wilson et al., 2001; Wright et al., 
1998).  
 
2.2.3.2   Deep digital flexor tendon 
 Multiple lesion types have been identified in the DDFT within the foot of horses affected 
with caudal heel pain, including dorsal abrasions or fibrillation, parasagittal splits, core lesions, 
and insertional lesions (Cillán-García et al., 2013; Schramme, 2011). Dorsal fibrillation is often 
identified and is thought to be an important part of the disease complex. Dorsal fibrillation is 
associated with erosions and loss of fibrocartilage from the flexor cortex of the navicular bone, 
 12 
and can contribute to the formation of adhesions between the DDFT and the navicular bone 
(Wright et al., 1998). This may perpetuate navicular bone damage and contribute to pain (Dyson 
and Murray, 2007a). Dorsal fibrillation of the DDFT has been identified in age-matched non-
lame horses, but parasagittal splits have only been identified in lame horses (Dyson et al., 2011a). 
Parasagittal splits that propagate along septal lines within the DDFT may also be part of the 
degenerative process, contributing to navicular bone flexor cortex damage due to exposed sharp 
edges of the tendon moving along the bone surface (Blunden et al., 2006b; Dyson et al., 2011a; 
Dyson and Murray, 2007a). Core lesions within the DDFT above the level of the navicular bone 
are most likely due to primary injury of the DDFT and are not considered part of the caudal heel 
pain syndrome (Cillán-García et al., 2013).  However, this primary damage to the DDFT may 
contribute to degeneration of the PTA over time (Dyson et al., 2011a; Sampson et al., 2009). 
Insertional lesions may include small core lesions, parasagittal splits, or entheseopathy at the 
insertion site (Blunden et al., 2009; Schramme, 2011). Insertional lesions may be a distal 
continuation of more proximal lesions (Schramme, 2011). Degenerative changes have been 
identified within the DDFT on histopathology. These include focal fibroplasia and 
fibrocartilaginous metaplasia within the dorsal aspect or intratendonous septa of the DDFT 
(Blunden et al., 2006a, 2006b; Dyson et al., 2012; Wright et al., 1998). Histological studies of 
advanced caudal heel pain have not been able to identify acute inflammatory changes in the 
DDFT, which suggests that the etiology is more degenerative (Blunden et al., 2006b; Busoni et 
al., 2005). To the author's knowledge, histologic evaluation of early caudal heel pain has not been 
published. 
 
2.2.3.3   Distal sesamoidean impar ligament and collateral sesamoidean ligaments 
 Abnormalities of the DSIL include insertional entheseophytosis, fibrocartilaginous 
metaplasia, focal fibroplasia, degeneration of collagen, fibre pattern irregularity, palmar border 
disruption with adhesions between the DSIL and DDFT, and generalized ligament thickening 
(Blunden et al., 2006a; Murray et al., 2006b). The DSIL may be abnormal in conjunction with 
distal border fragments of the navicular bone, and distal border fragments have been shown to 
consistently be embedded within the DSIL (Biggi and Dyson, 2011).  
 The CSL may vary in size and signal intensity on MRI, even when normal (Murray et al., 
2006b). Abnormalities noted in cases of caudal heel pain include ligament enlargement, adhesion 
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between the DDFT and CSL, and poorly defined margins of the CSL (Murray et al., 2006b; 
Sampson et al., 2009). Multiple retrospective studies have identified abnormalities in either the 
DSIL or the CSL in concurrence with injury to the other structures of the PTA (Dyson and 
Murray, 2007a; Gutierrez-Nibeyro et al., 2012; Murray et al., 2006b; Sampson et al., 2009). 
 
2.2.3.4   Navicular bursa 
 Inflammation of the navicular bursa (navicular bursitis) may be identified in cases of 
caudal heel pain (Murray et al., 2006b; Sampson et al., 2009). Inflammation is characterized by 
villous hypertrophy, synovial proliferation and hyperplasia, and abnormal distension of the bursa 
(Blunden et al., 2006a; Murray et al., 2006b; Pleasant et al., 1993). Primary navicular bursitis is 
rarely identified in the absence of other abnormalities in the palmar foot (Dyson and Murray, 
2007; Dyson et al., 2005; Sampson et al., 2009). Adhesions between the DDFT and the navicular 
bursa are often noted in conjunction with dorsal fibrillation of the DDFT (Sampson et al., 2009). 
 
2.2.3.5   Other(s) 
 Other structures within the foot may have mild to moderate abnormalities in conjunction 
with a diagnosis of caudal heel pain. Synovitis of varying severity may be present within the 
distal interphalangeal joint, characterized by effusion and synovial proliferation (Blunden et al., 
2006a; Gutierrez-Nibeyro et al., 2012; Murray et al., 2006b; Sampson et al., 2009). The digital 
flexor tendon sheath may also have increased synovial fluid (Gutierrez-Nibeyro et al., 2012; 
Sampson et al., 2009). Desmopathy of the collateral ligaments of the distal interphalangeal joint 
may be present in conjunction with a primary diagnosis of caudal heel pain (Blunden et al., 
2006a; Gutierrez-Nibeyro et al., 2012). The distal phalanx may have endosteal or palmar cortical 
irregularity at the insertion of the DDFT and/or DSIL, particularly when these structures are 
abnormal (Murray et al., 2006a).  
 
2.2.3.6   Unilateral vs bilateral disease 
 In unilaterally lame horses, abnormalities may be present in the PTA of the contralateral 
limb despite a lack of lameness in that limb (Gutierrez-Nibeyro et al., 2012; Murray et al., 
2006b). It is unknown if this is due to a change in weight bearing and increase in mechanical load 
on the non-lame limb, or if it is early degeneration of the PTA that will lead to lameness in the 
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future (Murray et al., 2006b). Gutierrez-Nibeyro et al. (2012) found that of 42 horses with 
unilateral forelimb lameness localized to the foot, 18 of those horses had MRI abnormalities 
within the PTA of the non-lame forelimb that was scanned for comparison purposes. Sampson et 
al. (2009) evaluated bilaterally lame horses only, and 93% of those had the most severe lesions in 
the lamest foot; however, 7% of horses had the most severe MRI lesions in the less lame foot.  
 Horses with unilateral caudal heel pain may have a different inciting cause than those 
with bilateral caudal heel pain (Baxter et al., 2011). If no abnormalities are present on imaging of 
the contralateral limb, the affected limb may have been subject to trauma such as a penetrating 
wound or foreign body, congenital disorder such as a bi-partite navicular bone, or chronic 
primary DDFT injury leading to navicular bone degeneration (Dyson et al., 2011a).   
 
2.2.4   Possible pathogenesis 
 
2.2.4.1   Cause of degeneration/syndrome 
 Caudal heel pain is poorly understood in terms of pathophysiology, and the sequence of 
injury between multiple podotrochlear structures is unknown (Dyson et al., 2011a). Three 
theories have been proposed: vascular compromise with ischemic events, mechanical trauma to 
the bone from constant compressive forces (arising from the DDFT), and chronic degeneration 
related to age and use, similar to osteoarthritis (Sampson et al., 2009; Widmer et al., 2000; 
Wright et al., 1998). An inability to reproduce the disease experimentally means that any 
suggested pathogenesis is somewhat speculative (Dyson et al., 2011a). 
 The vascular theory suggests that thrombosis of the navicular arteries and incomplete 
occlusion and atherosclerosis of the distal limb arteries results in ischemia of the navicular bone 
and therefore, degeneration of the fibrocartilage (Colles and Hickman, 1977; Fricker et al., 1982; 
Rijkenhuizen et al., 1989b, 1989c, 1989a). However, podotrochlear pathology or lameness cannot 
be reproduced by altering blood flow (Dyson et al., 2011; Ostblom et al., 1982; Pool et al., 1989), 
although obstructing venous outflow to cause congestion and increased bone marrow pressure 
within the navicular bone may result in pain and contribute to the development of clinically 
apparent lameness (Rijkenhuizen et al., 1989b; Svalastoga and Smith, 1983). Furthermore, 
hyperemia and increased vascularization within the navicular bone has been identified in horses 
with podotrochlear pathology (MacGregor, 1984; Ostblom et al., 1982), and vasculitis or 
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hypertensive vascular changes have been noted in diseased navicular bones histologically 
(Wright et al., 1998). More recently, ischemia and thrombosis were not noted on histologic 
examination of diseased navicular bones, indicating a lack of arterial occlusion (Blunden et al., 
2006a). This evidence has resulted in a rejection of this theory of pathogenesis (Dyson et al., 
2011a). 
 The theory of mechanical induction suggests that abnormal compressive forces cause 
trauma to the navicular bone and contribute to tissue degeneration (Rijkenhuizen, 2006; Wright et 
al., 1998). Abnormal forces result from either excessive loads placed on normal structures, or 
normal loads placed on abnormal structures (Baxter et al., 2011). The DDFT applies compressive 
forces to the navicular bone during both the stance and propulsive phases of the stride (Wilson et 
al., 2001). The amount of force applied to the navicular bone flexor surface is affected by 
conformation and gait. Excessive force on the PTA can result from poor hoof conformation such 
as long toes and low heels or a broken-back hoof pastern axis, improper medio-lateral balance of 
the foot, excessive body weight, and repetitive work on hard surfaces (Dabareiner and Carter, 
2003). Eliashar et al. (2004) determined that a decrease in distal phalanx palmar angle by one 
degree results in a 20 percent increase in force on the navicular bone in early stance in normal 
horses, so low heels may predispose horses to caudal heel pain due to increased force on the 
bone. Conversely, the peak force applied to the navicular bone is reduced by four percent for 
every degree of increase in the palmar angle of the distal phalanx. Horses affected by caudal heel 
pain tend to land toe first to guard the heel region, but this has been shown to double the force 
applied to the navicular bone by the DDFT as compared to normal horses (Wilson et al., 2001). 
This measured effect may create a feedback loop that perpetuates the abnormal biomechanical 
forces and disease progression once a structure in the heel region becomes injured and painful. 
The most prominent aspect of the navicular bone is the distal half of the flexor cortex, which is 
the most common location for erosions of the osseous surface (Sherlock et al., 2008; Wright et 
al., 1998). This is likely because this portion of the bone is subject to a higher degree of 
compressive force. It is assumed that all structures of the PTA experience similar biomechanical 
stresses to that of the navicular bone because altogether they act as a single unit (Dyson et al., 
2011a). 
 Based on the available evidence, mechanical induction is the most supported pathogenesis 
of the syndrome of caudal heel pain. Regardless, the pathologic features of caudal heel pain 
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lesions are similar to those of degenerative joint disease with the exception that the fibrocartilage 
of the flexor cortex of the navicular bone is affected versus hyaline cartilage that is typically 
affected in joints (Gabriel et al., 1998; Wright et al., 1998). Both degenerative joint disease and 
pathology of the navicular bone in cases of caudal heel pain are associated with thinned cartilage, 
reduced cartilage cellularity, entheseophyte or osteophyte formation, and subchondral bone 
erosion (Wright et al., 1998). Further, dorsal fibrillation and sagittal splitting of the DDFT are 
thought to be associated with a degenerative process, could cause ulceration of the fibrocartilage 
on the flexor surface of the navicular bone, and may result in adhesion formation and reduced 
function over time (Blunden et al., 2006b; Dyson and Murray, 2007a; Wright et al., 1998). The 
sequence of injury to the PTA is unknown, but it is possible that horses will be more predisposed 
to clinically significant lesions when several structures in the heel have mild degenerative 
changes (Dyson et al., 2011a). It has been speculated that the degeneration noted pathologically 
in end-stage caudal heel pain may be a result of a combination of pathogeneses, which gives 
reason for the chronic, progressive clinical syndrome that is often noted (Wright et al., 1998).  
 
2.2.4.2   Cause of pain in cases of caudal heel pain 
 Caudal heel pain is a significant source of pain and lameness for many horses. The 
particular source of pain can vary widely depending on the individual horse, may be due to more 
than one cause, and is difficult to determine apart from localization to the caudal heel region due 
to limitations with diagnostic anesthesia (Schumacher et al., 2001a, 2001b). Possible causes of 
pain include venous congestion of the navicular bone, increased intra-osseous pressure of the 
navicular bone or the distal phalanx at the insertion of the DSIL or DDFT, distention of the 
navicular bursa, adhesions between the DDFT and other PTA structures, disruption of the 
aforementioned adhesions, or disruption of the many sensory nerve endings within the CSL or 
DSIL (Bowker et al., 1997; Dyson et al., 2011a; Parkes et al., 2015). Inflammation causing pain 
may or may not be present in cases of caudal heel pain. Wright et al.  (1998) only found 
histological evidence of degeneration in advanced cases, while Van Wulfen and Bowker (1997) 
noted inflammation at the intersection of the DDFT and DSIL in clinically affected horses.  
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2.2.5   Prognosis of caudal heel pain and associated complications 
 Caudal heel pain is associated with a poor prognosis for disease resolution, especially if 
advanced degenerative changes are present (Dabareiner and Carter, 2003; Dyson and Murray, 
2007a; Rijkenhuizen, 2006). In particular, horses with deep digital flexor tendinopathy, navicular 
bone flexor surface erosions, synovial proliferation within the navicular bursa, and adhesions 
between the DDFT and associated structures are associated with an unsuccessful long-term 
outcome (Bell et al., 2009; Gutierrez-Nibeyro et al., 2010). Retrospective studies have 
determined that the presence of multiple abnormalities within the foot worsens the prognosis, 
despite attempting treatment (Gutierrez-Nibeyro et al., 2010; Lutter et al., 2015). Additionally, 
these and other reports indicate that the majority of horses studied have multiple abnormalities 
within the foot upon diagnosis (Dyson and Murray, 2007a). One study evaluating outcome 
following a combined treatment regimen of therapeutic shoeing, intrasynovial corticosteroids and 
extracorporeal shock wave therapy (ESWT) through the frog in a portion of horses only had 
22/56 (39.3%) horses return to their previous level of exercise for a period of time (Gutierrez-
nibeyro et al., 2010). Expected complications of caudal heel pain are dependent on the individual 
horse and treatment pursued. These can include complete fracture of the navicular bone, rupture 
of the DDFT, or chronic severe lameness that is not responsive to treatment and results in a 
decreased quality of life (Baxter et al., 2011).  
 As indicated above, there is currently no available cure for caudal heel pain, and treatment 
options are better thought of as pain management strategies (Baxter et al., 2011). Determining 
predisposing factors and attempting to prevent the disease is likely the better way to control 
navicular syndrome (Rijkenhuizen, 2006). The syndrome is unlikely to resolve completely, and 
partial improvement or temporary resolution of clinical signs can be expected for a variable time 
period in 40-50% of horses regardless of management used (Dyson et al., 2005; Rijkenhuizen, 
2006). Optimal management strategy and prognosis are dependent on the specific lesions within 
the foot of the individual horse, indicating MRI as an important part of the diagnostic process 
(Dabareiner and Carter, 2003; Dyson et al., 2005). 
 
2.3   Diagnosis of Caudal Heel Pain 
 The diagnostic criteria of caudal heel pain typically include a unilateral or bilateral 
forelimb lameness that is localized to the heel region of the foot with diagnostic anesthesia 
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(Dyson et al., 2011a; Dyson and Murray, 2007a; Parkes et al., 2015). Diagnostic imaging will 
show injury to one or more structures of the PTA (Bell et al., 2009; Dyson et al., 2011a; Dyson 
and Murray, 2007a; Parkes et al., 2015; Sampson et al., 2009). The diagnostic process involves a 
thorough lameness exam combined with one or more types of medical imaging. 
 
2.3.1   History, clinical signs, and typical case presentation 
 Caudal heel pain in the horse often presents as a unilateral or bilateral chronic forelimb 
lameness with varying clinical signs and duration (Dyson et al., 2011a). The classical 
presentation is a middle-aged gelding that is of Quarter Horse, Thoroughbred, or Warmblood 
lineage (Dabareiner and Carter, 2003; Sampson et al., 2008). Horses of all types and uses can be 
affected. The horse may present with intermittent, slowly worsening, bilateral forelimb lameness 
that is worse on hard or uneven terrain (Dabareiner and Carter, 2003; Parkes et al., 2015). 
However, an acute onset of severe unilateral forelimb lameness is also described concurrently 
with an MRI diagnosis of caudal heel pain (Dyson et al., 2011a).  
 
2.3.2   Lameness examination and diagnostic anesthesia 
 
2.3.2.1   Subjective lameness examination 
 Lameness in the horse is a clinical sign representing a source of pain or mechanical 
obstruction (de Grauw and van Loon, 2016). A thorough lameness examination requires 
observation of movement at the walk and trot in straight lines and on a circle in both directions to 
facilitate detection of a source of pain (Mitchell, 2012). Lame horses adapt their movement to 
reduce force on the painful limb by shifting their weight, abnormally moving a body part, 
changing joint angles, and altering foot flight (Dyson, 2011a). Vertical displacement of the head 
and rump from the normal plane are the most consistently observed gait alterations in lame 
horses. Horses with unilateral forelimb lameness may exhibit asymmetric head and neck 
movement (a “head nod”) to shift weight off of the lame limb (Baxter and Stashak, 2011a). If 
bilateral forelimb lameness is present, the severity of the head nod can be greatly reduced and a 
short, shuffling gait may be observed (Keegan et al., 2012). Lameness diagnosis from 
observation requires expertise and experience, and subjective lameness evaluation carries limited 
sensitivity, specificity, and repeatability between and among observers (Dyson, 2011a; Fuller et 
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al., 2006; Keegan et al., 2010). Reliability of subjective lameness scoring over time for a mild to 
moderate lameness by a single assessor is acceptable (Fuller et al., 2006), but agreement between 
observers for evaluation of mild lameness is poor (Donnell et al., 2015; Keegan et al., 2010). 
Subjective lameness assessment requires the use of a scoring system to record and characterize 
the lameness, and may be affected by observer bias (Keegan et al., 2012).  
 Several scoring systems exist for equine lameness exams. These include but are not 
limited to: a verbal rating scale with categories of consistency such as the one recommended by 
the American Association for Equine Practitioners (AAEP) (Swanson, 1984) (Table 2.1), a 
numerical rating system that assigns an increasing number based on severity in certain situations 
(Dyson, 2011a; Fuller et al., 2006), and a visual analogue scale (de Grauw and van Loon, 2016; 
Dyson, 2011a). Verbal rating scales can allow for more accurate score assignment to a particular 
lameness, but may also force a lameness to be scored in a category that is not a perfect fit (Fuller 
et al., 2006) and are affected by practitioner interpretation of the categories (Hewetson et al., 
2006). The scale recommended by the AAEP is anecdotally the most recognized scale used in 
North America. Regardless of the scoring system used, consistency in application by a single 
observer over time is important in both clinical case situations and when assessing lameness 
interventions in a research setting (de Grauw et al., 2016; Dyson, 2011a). 
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Table 2.1 Lameness Grading Scale, American Association of Equine Practitioners (Swanson, 
1984) 
 
Grade Description 
0 Lameness not perceptible under any circumstances 
1 Lameness difficult to observe; not consistently apparent regardless of circumstance 
(e.g. under saddle, circling, inclines, hard surfaces, etc.) 
2 Lameness difficult to observe at a walk or when trotting in a straight line but 
consistently apparent under certain circumstances (e.g. under saddle, circling, 
inclines, hard surfaces etc.) 
3 Lameness is consistently observable at a trot under all circumstances 
4 Lameness is obvious at a walk 
5 Lameness produces minimal weight bearing in motion and/or at rest or a complete 
inability to move 
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 Manipulations should be performed following visual identification of the primary lame 
limb to further localize the source of pain. Manipulations include flexion tests, hoof tester 
application, direct manipulation of a joint or soft tissue structure, wedge tests, and varus or valgus 
stress tests (Baxter and Stashak, 2011a). Flexion tests are nonspecific, false positives are 
common, and many normal horses may show positive responses (Mitchell, 2012). Response of 
the contralateral weight bearing limb should also be recorded following a flexion test. 
Anecdotally, horses affected by navicular syndrome may be worse after flexion of the 
contralateral limb and increased weight bearing on the affected limb. Hoof tester application 
permits deep palpation of the sole and other external structures of the foot (Baxter and Stashak, 
2011a), but findings may be nonspecific and should be interpreted cautiously (Parkes et al., 
2015). 
 A lameness examination of a horse affected by caudal heel pain often reveals a short-
strided gait in the forelimbs, and the lameness may be exacerbated when the most lame limb is on 
the inside of the lunging circle (Dabareiner and Carter, 2003). The lameness can be inconsistent 
in severity between multiple examinations and a daily fluctuation in lameness severity has even 
been noted in some affected horses (Parkes et al., 2015). Response to distal limb flexion and hoof 
tester application is variable and not predictive of a diagnosis for caudal heel pain (Parkes et al., 
2015). A mild increase in lameness severity following flexion of the distal limb is a common, 
nonspecific finding in many horses that are exercised regularly and is not necessarily indicative 
of lameness originating from the distal limb (Baxter and Stashak, 2011a). 
 
2.3.2.2   Objective lameness evaluation 
 Although subjective gait assessment is the time-honoured method for lameness evaluation 
in equine practice, concurrent real-time objective assessment of the equine gait is gaining 
popularity. There is an increasing availability of easy-to-use commercial systems that are 
scientifically validated to quantify equine lameness and have increased accuracy and sensitivity 
when compared to subjective examinations (Donnell et al., 2015; Moorman et al., 2017).  The 
Lameness Locator® is one such commercially available inertial sensor system used for objective 
kinematic gait analysis in horses and is anecdotally the most widely used system. 
 Inertial sensor systems vary in specific configuration and capabilities. The Lameness 
Locator® uses two accelerometers attached to the head and pelvis on midline, and one gyroscope 
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attached to the right front pastern (Keegan et al., 2012). These sensors transmit measurements 
wirelessly to the accompanying software that include vertical displacement of the head and pelvis 
from the normal position of the sensor (measured in millimeters) in relation to the angular 
velocity of the right forelimb. This communicates the position of the limb in space and which 
limbs are on the ground at the trot to the accompanying software (Keegan et al., 2012, 2011). 
Asymmetric vertical movement of the torso reflects a reduction in ground reaction forces of a 
limb and indicates lameness (Keegan et al., 2012). The software can then localize a lameness to a 
particular limb based on the association of head or pelvic movement to the angular velocity of the 
right forelimb, and will quantify this asymmetry in torso movement between the left and right 
halves of the stride to determine the severity of the lameness (Keegan, 2011; Keegan et al., 2012, 
2011). The Lameness Locator® inertial sensor system has been shown to be significantly more 
sensitive than subjective lameness evaluation by an experienced veterinarian for accurately 
detecting lameness in the horse (McCracken et al., 2012).   
 Another available method of objective lameness assessment is the use of a stationary 
force plate. The force plate has historically been considered the gold standard for objective 
lameness measurement in horses (Keegan et al., 2012). Force plate analysis of lameness measures 
peak vertical force and stance duration of a single limb (Donnell et al., 2015). Reduction in these 
parameters indicates a lameness (Keegan et al., 2012). Unfortunately, force plate analysis is 
impractical in a clinical setting because only one stride is recorded at a time and the force plate is 
limited to a stationary location (Donnell et al., 2015). Early work showed that vertical torso 
movement asymmetry measurements produced by inertial sensor systems have similar precision 
for lameness detection when compared to force plate analysis of lameness (Keegan et al., 2012). 
Stationary force plate analysis has recently been shown to have poor agreement with subjective 
evaluation when identifying mild forelimb lameness, and decreased sensitivity and agreement 
compared to inertial sensor system analysis (Donnell et al., 2015). While the two methods of 
measurement are evaluating different parameters of lameness, there is strong correlation when 
used to evaluate moderate forelimb lameness, and agreement increases as the severity of 
lameness increases (Donnell et al., 2015; Keegan et al., 2012). Asymmetric vertical movement of 
the torso as measured by inertial sensor systems is directly associated with measured vertical 
ground reaction forces, but measurement of vertical torso movement inherently produces more 
variable data compared to measurement of ground reaction forces by force plate evaluation, 
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likely due to the higher number of strides evaluated at a single time and movement of the torso 
unrelated to lameness during the gait examination. Accurate interpretation of kinematic gait 
analysis data relies on experience with the software, and is more useful when used in conjunction 
with the eye of a skilled lameness clinician (Donnell et al., 2015).  
 Both force plate and kinematic gait analysis have limitations when evaluating multiple 
limb lameness, such as in horses with bilateral caudal heel pain. In cases of bilateral forelimb 
lameness, each limb is measured individually by the force plate and compared to recognized 
normal values based on the body weight of the horse. This method can identify abnormal values 
for each forelimb compared to normal values, but takes a considerable amount of time to achieve 
useful data and can only be performed on a straight line. An inertial sensor system may be unable 
to identify a bilateral forelimb lameness in a straight line if the vertical torso movements are 
equal for each trot stride, although the system can be used to identify asymmetry while the horse 
is trotting in a circle. In horses with bilateral caudal heel pain, vertical torso movement 
asymmetry is theoretically decreased on the straight line, resulting in a short and choppy gait 
instead of obvious asymmetric movement (Keegan et al., 2012). While limitations are evident, 
the utility of objective lameness measurement will increase as research advances. In the interim, 
objective lameness evaluation with an inertial sensor system has been shown to increase 
sensitivity of lameness detection and reduce bias in lameness observation over time or after 
treatments (Keegan et al., 2013, 2012). Thus, kinematic gait analysis may serve as a valuable 
adjunct to subjective lameness evaluation and provides objective data when used in a research 
setting. 
 
2.3.2.3   Diagnostic anesthesia 
 Perineural or regional nerve blocks and intra-synovial anesthesia techniques are useful for 
localization of pain during a lameness examination. This increases the significance of imaging 
findings by specifying a region of focus for diagnostic imaging (Baxter and Stashak, 2011b). 
However, consistency and specificity of the information gained by regional anesthesia is 
controversial (Schumacher et al., 2013). Perineural or regional anesthesia is typically employed 
to localize a region as opposed to the specific site of pain, such as a joint. This method should be 
used in a systematic manner, starting as distal as possible and moving proximally if adequate 
improvement in the lameness is not achieved (Mitchell, 2012). 
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 The most distal location for perineural anesthesia on the limb is located axial and distal to 
the proximal margin of the collateral cartilages of the foot and is commonly referred to as the 
palmar digital nerve block (Mitchell, 2012; Schumacher et al., 2013). The structures generally 
desensitized by this nerve block include the sole, most of the coronary band, the PTA and soft 
tissues of the heel, the distal interphalangeal joint and collateral ligaments of the distal 
interphalangeal joint, and portions of the distal sesamoidean ligaments (Pilsworth and Dyson, 
2015; Schumacher et al., 2013). However, depending on time between administration of the 
block and observation of lameness, proximal diffusion of the anesthetic solution can occur 
(Schumacher et al., 2013). In addition, this block may anesthetize or partially anesthetize the 
proximal interphalangeal joint, the proximal phalanx, and occasionally the metacarpophalangeal 
joint (Baxter and Stashak, 2011b; Pilsworth and Dyson, 2015; Schumacher et al., 2013). If the 
palmar digital nerve block does not resolve the lameness, anesthesia of the palmar nerves at the 
level of the proximal sesamoids (abaxial sesamoid nerve block) effectively anesthetizes the entire 
digit, including the foot, middle phalanx, the proximal interphalangeal joint, distopalmar aspects 
of the proximal phalanx, the distal portion of superficial digital flexor tendon and DDFT, the 
distal sesamoidean ligaments, and the digital annular ligament (Baxter and Stashak, 2011b).  
 Horses with caudal heel pain often show a marked reduction in lameness severity 
following anesthesia of the palmar digital nerves (Dabareiner and Carter, 2003; Dyson et al., 
2011a; Sampson et al., 2008). In a recent study, approximately 45-55% of horses displayed 
significant improvement but not complete resolution following a low palmar digital nerve block. 
A higher proportion of horses in this study (75-90%) required an abaxial palmar nerve block to 
eliminate the lameness (Parkes et al., 2015). The reason for this could be two-fold: one, caudal 
heel pain tends to be chronic and/or deep pain resulting in incomplete response to local perineural 
anesthesia at the most distal level; two, there is a possibility of adhesions being present between 
the deep digital flexor tendon and the navicular bone which can result in a mechanical 
abnormality leading to pain referred proximal in the limb and thus an incomplete response to 
nerve blocks (Parkes et al., 2015). In many horses, the noted lameness may switch to the 
opposing forelimb following diagnostic anesthesia of the palmar digital nerves of the more 
severely affected forelimb (Baxter et al., 2011). 
 Anesthesia of the distal interphalangeal joint and/or the navicular bursa has the potential 
to further specify the site of pain. It was previously thought that a positive response to distal 
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interphalangeal joint anesthesia indicated that the source of lameness originated from the joint 
and not the heel region (Baxter et al., 2011), but it has been demonstrated that this is not true 
(Schumacher et al., 2001a). Anesthesia of the distal interphalangeal joint not only anesthetizes 
the distal interphalangeal joint, the navicular bone, and the PTA, but can also provide anesthesia 
to the sole (Schumacher et al., 2001a). It has been shown that 16-36% of horses with a clinical 
diagnosis of navicular syndrome improve significantly to anesthesia of the distal interphalangeal 
joint, and some reports are higher (Baxter et al., 2011; Parkes et al., 2015; Schumacher et al., 
2001a). The palmar digital nerves are closely located to the palmar outpouchings of the distal 
interphalangeal joint and so may be anesthetized simply due to proximity (Schumacher et al., 
2001a). Additionally, the distal interphalangeal joint has some degree of communication with the 
PTA which allows for anesthetic diffusion (Olive and Videau, 2017; Schumacher et al., 2013). 
Some authors state that anesthesia of the navicular bursa may be the most specific diagnostic 
anesthesia technique to localize the source of pain in horses with navicular syndrome 
(Schumacher et al., 2013). However, recent work indicates that a poor response to navicular 
bursa anesthesia does not rule out the presence of significant pathology of the PTA (Parkes et al., 
2015). 
 
2.3.3   Radiographic evaluation 
 Radiography is typically the initial imaging modality used for lameness diagnosis 
following localization of the source of pain (Dyson, 2011b). The minimum recommended views 
to evaluate the navicular bone and associated structures of the forelimbs include: lateromedial, 
dorso 60º proximal palmarodistal oblique, and palmaro 45º proximal palmarodistal (navicular 
skyline) oblique views (Dyson, 2011b). Further radiographic views that can provide additional 
information include a dorsopalmar projection and multiple oblique projections of the digit 
(Baxter et al., 2011; Dyson, 2011b). Thorough cleaning and preparation of the foot is paramount. 
This involves removing dirt and debris, paring the frog or sole, removing shoes, trimming the 
foot if necessary, and packing the sulci and frog with petroleum jelly or modelling dough to 
eliminate air that can create radiolucent artifacts. When obtaining the radiographs, particular 
attention must be given to appropriate positioning of the foot, especially for the navicular skyline 
projection. Improper positioning can artefactually increase the navicular bone medullary opacity 
(Dyson, 2011b). 
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 Multiple radiographic abnormalities of the navicular bone have been described as part of a 
diagnosis of caudal heel pain. These include: proximal border entheseophytes, proximal or distal 
extension of the flexor surface, distal border fragments, enlarged synovial invaginations, new 
bone at the sagittal ridge, increased cortical thickness of the flexor surface, bi- or tri-partite 
navicular bone, osseous cyst-like lesions in the medullary cavity, radiolucencies in the flexor 
cortex, and medullary sclerosis, with the latter three abnormalities being most indicative of 
navicular bone pathology (Dabareiner and Carter, 2003; Dyson, 2011b). Normal variations that 
should not be considered to suggest navicular bone pathology or caudal heel pain include a 
smoothly outlined depression in the sagittal ridge on the lateromedial view and a crescent shaped 
lucent zone in the sagittal ridge on the navicular skyline view (Dyson, 2011b). Bi- or tri- partite 
navicular bones are probable congenital abnormalities that may be noted in a sound horse, but 
tend to cause lameness over time that is associated with degeneration of the navicular bone (van 
der Zaag et al., 2016). The shape of the proximal articular border of the navicular bone on 
radiographs has been shown to be genetically determined in Dutch Warmbloods (Bos et al., 
1986). Horses with a concave proximal articular border of the navicular bone on the dorso 60º 
proximal palmarodistal oblique view may be more susceptible to the development of navicular 
syndrome (Dik et al., 2001a). It is important to note that a radiographically normal navicular bone 
does not rule out navicular bone pathology, highlighting the importance of advanced diagnostic 
imaging (Dyson et al., 2011a; Sampson et al., 2009). Some horses never develop any 
radiographic evidence of disease but still display clinical lameness and have MRI findings 
consistent with caudal heel pain, including osseous abnormalities (Dabareiner and Carter, 2003; 
Dyson et al., 2011a). 
 A grading system has been developed and revised to improve objectivity when assessing 
the navicular bone with radiographs (Biggi and Dyson, 2012, 2010; Dyson, 2008; Parkes et al., 
2015). The grade ranges from 0-3, with 0 being clinically normal and 3 representing significant 
navicular bone pathology evident on radiographs. The radiologic grade can underestimate the 
severity of pathology within the navicular bone and other structures of the PTA (Dyson, 2008). 
Significant correlations have been determined between the overall radiologic grade and MRI 
grade of the navicular bone (Biggi and Dyson, 2010). 
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2.3.4   Ultrasound evaluation 
 Ultrasound has been used in a limited capacity to evaluate the palmar soft tissue structures 
of the distal pastern and the PTA (Bolen et al., 2007; Busoni and Denoix, 2001; Dabareiner and 
Carter, 2003). Imaging is performed percutaneously through the palmar pastern and the frog of 
the hoof. This imaging technique can provide information regarding the distal DDFT and the 
digital cushion, as well as the flexor cortex of the navicular bone and portions of the DSIL and 
CSL (Bolen et al., 2007; Busoni and Denoix, 2001). Considerable preparation is required to 
obtain adequate images, and the foot size and frog conformation of the horse determines the 
beam angle and area of imaging (Busoni and Denoix, 2001). The accuracy and utility of this 
imaging modality for the heel region has been questioned due to the advent of more advanced 
imaging techniques (Baxter et al., 2011).  
 
2.3.5   Magnetic resonance imaging 
 Magnetic resonance imaging is the preferred diagnostic imaging modality for the soft 
tissues of the equine foot, particularly in cases that do not have any apparent radiographic 
changes (Dyson et al., 2011a; Werpy, 2012). When directly compared to computed tomography 
(CT), MRI does not show the same degree of osseous detail but is capable of identifying the same 
bone lesions with greater soft tissue detail (Werpy, 2012; Widmer et al., 2000). Use of MRI in 
cases of caudal heel pain has allowed the identification of soft tissue lesions in the PTA, 
especially when performed early in clinical manifestation and prior to any obvious radiographic 
changes (Dyson et al., 2012, 2011a; Dyson and Murray, 2007a; Sampson et al., 2009). Both low-
field and high-field MRI is available, though not often at the same facility. Standing low-field 
MRI is advantageous in that it does not require general anesthesia for the horse, but may be 
inferior to high-field MRI for the diagnosis of small lesions (Werpy, 2007). However, low-field 
MRI can still accurately diagnose many injuries in horses (Gutierrez-Nibeyro et al., 2012; Werpy, 
2007).  
 Using MRI, many abnormalities have been identified in the PTA of horses affected with 
caudal heel pain. Combinations of injuries within a single affected foot are a common finding 
(Dyson et al., 2012, 2011a; Dyson and Murray, 2007a; Sampson et al., 2009). A variety of 
lesions have been described, as stated earlier in section 2.2.3. Abnormal medullary signal 
intensity within the navicular bone noted on fat-suppressed MRI sequences was the most frequent 
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observation in one study, which indicates possible inflammation, hemorrhage, synovial fluid, 
bone necrosis, or fibrosis, all of which are indiscernible on MRI (Sampson et al., 2009). 
However, navicular bone pathology in the absence of pathology of the other structures of the 
PTA is rare, and lesions of the navicular bone have been observed in conjunction with pathology 
of the DDFT, CSL, DSIL, the navicular bursa, the distal interphalangeal joint, and the collateral 
ligaments of the distal interphalangeal joint (Baxter et al., 2011; Dyson et al., 2012; Dyson and 
Murray, 2007a; Parkes et al., 2015).  
 The frequency and type of soft tissue pathology noted on MRI varies; deep digital flexor 
tendinopathy is common with incidence ranging from 44-86% of feet examined (Dyson and 
Murray, 2007a; Sampson et al., 2009). Multiple lesions have been noted in the DDFT, with 
dorsal fibrillation, parasagittal splits, core lesions, insertional lesions, and combinations of lesions 
most commonly reported (Dyson et al., 2011a, 2003; Dyson and Murray, 2007a; Lutter et al., 
2015). Due to the amount of detail available from MRI, there is some difficulty in determining 
which abnormality is the primary source of pain in the foot when multiple injuries are found. In 
addition, abnormalities of the PTA have been identified in a moderate percentage (27%) of non-
lame limbs on MRI (Murray et al., 2006b). These findings could indicate anatomical variation, 
adaptation to biomechanical forces, repair of previous injuries, or early subclinical changes that 
could predispose horses to future lameness. Histopathologic findings correlate with the majority 
of lesions identified on MRI, validating this imaging modality as a diagnostic procedure for 
horses affected with foot pain (Dyson et al., 2012; Murray et al., 2006a). A grading system has 
been developed for MRI of the foot based on signal intensity and presence of abnormalities in 
comparison to normal (non-lame) feet and histopathological studies (Biggi and Dyson, 2011; 
Murray et al., 2006a, 2006b). 
 
2.3.6   Computed tomography 
 Computed tomography (CT) provides good spatial resolution of the equine foot and is the 
best imaging modality to evaluate osseous pathology (Widmer et al., 2000). This imaging 
modality removes superimposition, allowing evaluation of small abnormalities, especially the 
presence and size of navicular bone distal border fragments (Groth et al., 2009; Widmer et al., 
2000). Some soft tissue abnormalities in the foot can be detected using CT; intra-arterial contrast 
can improve imaging of soft tissues, but the quality of soft tissue imaging achieved using these 
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methods is still surpassed by MRI. In addition, the need for general anesthesia and limited access 
to CT decreases the usefulness of this modality (Baxter et al., 2011).  
 
2.3.7   Nuclear scintigraphy 
 Nuclear scintigraphy provides information about the metabolic activity within tissues 
based on the uptake of a radiopharmaceutical substance (Dyson, 2002; Dyson and Murray, 
2007b). Increased radiopharmaceutical uptake is reflective of abnormal osteoblastic activity 
within a bone, which can represent either adaptive or pathologic responses of that bone to 
external forces (Dyson and Murray, 2007c). Increased osteoblastic activity is not present in all 
cases of navicular bone pathology or caudal heel pain (Dyson et al., 2012; Dyson and Murray, 
2007c). If necrosis of the bone is the primary pathogenesis, only increased osteoclastic activity 
will occur which could result in normal radiopharmaceutical uptake on scintigraphic examination 
despite lesions consistent with navicular syndrome (Dyson and Murray, 2007c). Additionally, 
horses with a low heel conformation but no lesions consistent with navicular syndrome can have 
increased radiopharmaceutical uptake in the navicular bone or at the insertion of the DDFT, 
possibly due to low heel conformation increasing compressive forces exerted by the DDFT 
(Dyson, 2002; Eliashar et al., 2004). Therefore, scintigraphy may be a useful adjunct imaging 
modality in cases of caudal heel pain, but has low sensitivity and specificity compared to MRI 
(Baxter et al., 2011). 
 
2.3.8   Bursography and navicular bursoscopy 
 Navicular bursography and bursoscopy are less commonly used to diagnose caudal heel 
pain (Baxter et al., 2011; Dabareiner and Carter, 2003). Positive contrast radiography of the 
navicular bursa can highlight the navicular bone flexor surface, possibly displaying any 
fibrocartilage change and abnormalities of the dorsal surface of the DDFT, and has been shown 
to be superior to plain radiography for finding flexor surface pathology (Turner, 1998). However, 
this technique is used infrequently due to the increasing availability of MRI (Baxter et al., 2011). 
Endoscopy of the navicular bursa (bursoscopy) is more frequently used in cases of suspected 
septic bursitis, but can be employed as both a diagnostic and therapeutic option to evaluate the 
flexor surface of the navicular bone, the navicular bursa, CSL, and the dorsal aspect of the DDFT 
(Mählmann et al., 2015; Smith and Wright, 2012). Bursoscopy requires general anesthesia, but 
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may be better at identifying fibrocartilage defects on the flexor surface of the navicular bone and 
adhesions when compared to MRI (Mählmann et al., 2015). In this way, navicular bursoscopy 
may provide a more complete diagnostic picture for caudal heel pain when combined with 
advanced imaging techniques.  
 
2.3.9   Histopathology 
 Gross pathology and histopathology are not useful in the ante mortem diagnosis of caudal 
heel pain in horses. However, the correlation of diagnostic imaging to pathologic findings 
supports the use of MRI as a gold standard diagnostic modality for injuries within the foot 
(Dyson et al., 2012; Murray et al., 2006a). Gross post mortem abnormalities of the navicular bone 
are likely to be present in cases of advanced caudal heel pain. These include: full thickness 
fibrocartilage defects on the flexor surface, erosion of the flexor cortex of the navicular bone, 
lysis of the navicular bone medulla, fibrillation of the dorsal aspect of the DDFT, parasagittal 
splits or core lesions within the DDFT, and adhesions between the DDFT and the navicular bone 
(Wright et al., 1998). Gross post mortem evaluation of early caudal heel pain may only show 
mild degrees of the aforementioned abnormalities (Blunden et al., 2006a, 2006b). The reader is 
referred to section 2.2.3 for further information regarding histopathologic findings supporting a 
diagnosis of caudal heel pain.  
  
2.4   Treatment of caudal heel pain 
 Many treatment options have been described for caudal heel pain, but most give 
inconsistent results for both alleviating lameness and reversing disease changes. There is no 
single treatment with excellent efficacy, and often a combination of treatments is required to 
target the presumed or identified lesions (Bell et al., 2009; Dyson et al., 2005; Gutierrez-Nibeyro 
et al., 2010; Whitfield et al., 2016). Individual horse factors must be considered, such as the 
intended use of the horse, expectations of the owner, lameness severity, results of diagnostic 
procedures or lack thereof, previous treatments performed, and hoof conformation (Baxter et al., 
2011; Dabareiner and Carter, 2003). The use of MRI in the diagnostic process allows for the 
planning of a more specific treatment plan for the individual horse. Typically, treatments are 
combined to produce a management strategy based on the results of diagnostic imaging. The 
most common treatment combinations include therapeutic trimming or shoeing coupled with 
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systemic and/or intra-synovial anti-inflammatory medication and a variable period of rest and 
rehabilitation (Dabareiner and Carter, 2003). Other approaches may include vasoactive 
medications, bone-modulating medications (bisphosphonates), physical therapies such as 
extracorporeal shock wave therapy (ESWT), alternative therapies such as acupuncture, and 
palliative surgical procedures such as a palmar digital neurectomy (Baxter et al., 2011; 
Dabareiner and Carter, 2003; Rijkenhuizen, 2006).  
 
2.4.1   Therapeutic trimming and shoes 
 Corrective trimming, with or without shoes, should be the first line of treatment in all 
cases of caudal heel pain. Many trimming or shoeing practices have been described, but the 
correction of any hoof imbalance should be the first objective (Rijkenhuizen, 2006; Schoonover 
et al., 2005). Once the foot is balanced, additional methods commonly employed involve raising 
the palmar angle of the distal phalanx by increasing heel mass or elevating the heel (Eliashar et 
al., 2004; Schoonover et al., 2005), but providing heel support without elevation may also 
alleviate lameness (Schoonover et al., 2005). The palmar angle of the distal phalanx is defined as 
the angle made by the palmar border of the bone and the surface of the ground. It is known that a 
low palmar angle (less than 2-3º) causes increased extension of the distal interphalangeal joint 
(Eggleston, 2012; Eliashar et al., 2004; Redden, 2003) and that decreasing the palmar angle by 
one degree results in a twenty percent increase in the peak compressive force the navicular bone 
experiences (Eliashar et al., 2004). Conversely, increasing the palmar angle and improving heel 
support reduces the force exerted on the navicular bone by the DDFT during distal 
interphalangeal joint extension due to increasing the area of load distribution under the heel. 
However, this result depends on the type of shoe used and is not noted in healthy horses, nor in 
all affected horses (Eliashar, 2007; Willemen et al., 1999). Raising the palmar angle can be 
achieved through various techniques including careful trimming over time, various wedge pads, 
or different types of wedge shoes.  
 Techniques to provide more heel support include the use of a bar shoe, onion shoe, or a 
shoe fit full in the quarters to give more caudal support (Schoonover et al., 2005). In addition to 
increasing heel height, other methods often employed for horses with caudal heel pain include 
easing the breakover of the foot by decreasing toe length and/or using a rolled toe or rockered toe 
shoe (Eliashar et al., 2002). The breakover of the foot is defined as the period of rotation of the 
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heels around the point of the toe as the foot leaves the ground (Eliashar et al., 2002). Reducing 
the length of the toe can decrease the rotation period and create more gradual hoof movement, but 
has not been shown to reduce force on the navicular bone (Eliashar, 2007; Eliashar et al., 2002).   
 Regardless of method used, it is important to have good quality radiographs to guide 
corrective trimming and shoeing, as the degree of heel collapse noted externally does not 
correlate with the palmar angle of the distal phalanx (Dyson et al., 2011b). Case management 
should also include regular farrier work every four to eight weeks, and the willingness to use 
many different techniques, as not every horse will find relief from the same type of shoe 
(Dabareiner and Carter, 2003; Moleman et al., 2006). Additionally, extended shoeing intervals 
can increase the tension on the DDFT and the compressive force on the navicular bone by 
increasing extension of the distal interphalangeal joint (Cillán-García et al., 2013; Moleman et al., 
2006). Horses with good foot conformation and acceptable farrier management at the time of 
diagnosis may not show much improvement after therapeutic shoeing. In horses that have not had 
regular hoof care, proper trimming by itself may provide correct hoof balance such that shoes or 
pads are unnecessary to achieve optimal hoof conformation and clinical improvement. Some 
horses with permanent structural damage such as navicular bone flexor surface erosions may not 
improve significantly with therapeutic farrier work (Dabareiner and Carter, 2003).  
 
2.4.2   Systemic anti-inflammatories 
 Systemic non-steroidal anti-inflammatory medications are frequently used to manage 
horses with caudal heel pain (Rijkenhuizen, 2006). Phenylbutazone, flunixin meglumine, and 
firocoxib are the most commonly used medications and all options provide effective pain relief 
and reduction of inflammation through inhibition of prostaglandin (Baxter et al., 2011; 
Dabareiner and Carter, 2003; Moses and Bertone, 2002). Both phenylbutazone and flunixin have 
been shown to have good success for reduction of lameness in cases of caudal heel pain (Erkert et 
al., 2005), and firocoxib has been validated for relief of chronic lameness caused by caudal heel 
pain (Back et al., 2009). It is questionable if these medications target the disease process 
associated with caudal heel pain, because there is minimal evidence of inflammation in the 
affected structures, especially in cases of advanced disease (Gutierrez-Nibeyro et al., 2010). 
There are risks associated with the use of these medications, and although rare, administration of 
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systemic non-steroidal anti-inflammatory medications has been linked to right dorsal colitis, 
acute renal failure, and gastric ulceration (Moses and Bertone, 2002).  
 
2.4.3   Intra-synovial injections and medications 
 Intra-synovial medication of either the distal interphalangeal joint, the navicular bursa, or 
both in combination is commonly employed for management of caudal heel pain (Baxter et al., 
2011). Medications used for intra-synovial injections include: corticosteroids such as 
triamcinolone acetonide or methylprednisolone acetate, sodium hyaluronate, corticosteroids 
combined with hyaluronate, or polysulfated glycosaminoglycans (Ferris et al., 2011). 
Corticosteroids reduce pain and effusion associated with synovitis and induced osteoarthritis in 
the horse due to their potent anti-inflammatory effects (Frisbie et al., 1997). In addition, they 
decrease the expression of pro-inflammatory molecules in cartilage and synovial membranes (de 
Grauw et al., 2016). However, some corticosteroids are detrimental to articular cartilage 
morphology and composition, especially methylprednisolone acetate (de Grauw et al., 2016; 
McIlwraith, 2010). Sodium hyaluronate has been shown to decrease lameness and provide anti-
inflammatory effects when injected into a diseased joint, possibly by reducing friction, cartilage 
fibrillation and synovial prostaglandin release (de Grauw et al., 2016). Until recently, it was 
thought that the use of corticosteroids and sodium hyaluronate in combination was more 
beneficial to treat joint disease than simply using corticosteroids and may mitigate the negative 
side effects of corticosteroids (de Grauw et al., 2016; Schoonover et al., 2005). However, the use 
of this medication may be equivocal since de Grauw et al. (2016) demonstrated that the combined 
use of sodium hyaluronate and triamcinolone does not improve short term lameness outcomes in 
horses with osteoarthritis. 
 Anatomical knowledge suggests that medication of the distal interphalangeal joint should 
provide some relief to the structures of the PTA, but the clinical response in individual horses can 
be inconsistent and disappointing (Schoonover et al., 2005). The distal interphalangeal joint was 
medicated in 56 horses and required repeat injection due to lack of response in 23 horses; 
however, repeated injections did not significantly affect the outcome (Gutierrez-Nibeyro et al., 
2010). 
 Medication of the navicular bursa with corticosteroids to treat caudal heel pain has been 
described in several reports, with 60-80% of treated horses quickly returning to their intended use 
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for variable periods of time (Bell et al., 2009; Dabareiner et al., 2003; Marsh et al., 2012; 
Verschooten et al., 1990). Medications used include triamcinolone acetate, methylprednisolone 
acetate, sodium hyaluronate, and amikacin, all at varying doses determined by clinician 
preference. Both Marsh et al. (2012) and Bell et al. (2009) found that MRI diagnosis influenced 
response to treatment, with navicular bone flexor surface defects or the presence of multiple 
concurrent abnormalities resulting in significantly worse outcomes than other lesion groups. 
Mean duration of lameness resolution ranged from 4.6 to 9.6 months following navicular bursa 
injection, although some horses only improved for 2-3 months (Bell et al., 2009; Dabareiner et 
al., 2003; Marsh et al., 2012). Medication of the navicular bursa presents more possible adverse 
effects than just those expected for synoviocentesis. Synovial sepsis and the risks associated with 
using corticosteroids cannot be ignored, but all described palmar approaches to the navicular 
bursa involve penetration of the DDFT. While there is no evidence indicating that injection of the 
bursa will directly cause rupture of the DDFT, it has been reported as an unfortunate outcome by 
one group and is a catastrophic risk so warrants careful consideration (Dabareiner et al., 2003). 
Other approaches have since been developed to avoid penetration of the DDFT (Daniel et al., 
2016). In addition, the use of corticosteroids concurrently with soft tissue injuries such as those 
often diagnosed by MRI may inhibit the inflammatory response and therefore healing of those 
structures (Dowling et al., 2000). 
 
2.4.4   Rest 
 Long periods of rest are typically not recommended nor successful for horses with caudal 
heel pain due to the progressive, degenerative nature of the disease. However, a short duration of 
rest with a gradual return to work may help to decrease soft tissue inflammation that may be 
present (Dabareiner and Carter, 2003). Proper adherence to a prescribed rest and rehabilitation 
protocol was an important factor for an improved outcome in 56 horses evaluated with MRI. This 
protocol involved a 4 to 8 week period of stall rest followed by a 4 to 8 week period of controlled 
exercise with a gradual return to the previous level of activity (Gutierrez-Nibeyro et al., 2010).  
 
2.4.5   Bisphosphonates 
 Bisphosphonates are a class of drug that are potent bone resorption inhibitors (Whitfield 
et al., 2016). Drugs used clinically in horses in this class include tiludronate and clodronate; 
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pamidronate and zoledronate have been investigated in a research setting (McLellan, 2017). 
These drugs bind to calcium and other divalent metal ions within the bloodstream, but also to 
bone mineral in areas of active osseous remodeling. Bisphosphonates act directly on osteoclasts 
and cause decreased cell recruitment, activity and lifespan, effectively inhibiting or reducing 
bone resorption (McLellan, 2017; Whitfield et al., 2016). Bisphosphonates have also been shown 
to have anti-inflammatory properties in non-equine species through inhibition of monocytic 
cytokine and nitric oxide secretion (Whitfield et al., 2016). Bone remodeling and excessive 
resorption is often a characteristic of caudal heel pain, likely due to increased mechanical load on 
the navicular bone (Dyson et al., 2011a). It is known that the bone resorption rate is increased in 
relation to bone formation in a diseased navicular bone compared to a normal bone (Denoix et al., 
2003). 
 Tiludronate sodium has been shown to cause a reduction in lameness grade in horses 
diagnosed with caudal heel pain when administered systemically at a single intravenous dose of 
1.0  mg/kg (Denoix et al., 2003; Whitfield et al., 2016). This reduction of lameness is primarily 
noted in horses with clinical signs of less than six months duration (Denoix et al., 2003). Only 
radiography has been used to determine effects of tiludronate on navicular bone pathology, and 
no radiographically evident effects have been noted, with reports suggesting that radiography is 
not a sensitive enough modality to detect the possible slight changes in bone density following 
administration of tiludronate to horses (Denoix et al., 2003; Whitfield et al., 2016). Therefore, the 
evidence only supports the use of tiludronate as a treatment to manage clinical signs associated 
with caudal heel pain. Clodronate is approved for use in horses to mitigate clinical signs 
associated with caudal heel pain. The research performed for drug approval describes mild 
improvement in lameness six weeks after administration of clodronate to horses diagnosed with 
caudal heel pain, but loss of this improvement six months following treatment (Frevel et al., 
2014). There is the potential for significant side effects with bisphosphonate use in horses, some 
of which are suspected but as of yet unknown due to a lack of long-term safety information. Both 
colic symptoms and abnormalities in renal parameters have been associated with the use of 
tiludronate and clodronate (Soto and Chiappe, 2014). Additionally, bisphosphonates may inhibit 
bone microcrack healing and reduce healing of stress fractures, and have been linked to 
osteopetrosis and mandibular necrosis in people (McLellan, 2017).  
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 2.4.6   Isoxsuprine 
 Isoxsuprine is a beta-adrenergic agonist with vasodilatory properties that has been used 
systemically via oral administration for the management of caudal heel pain. The mechanism of 
action is unknown, oral bioavailability is poor, and no measurable cardiovascular effects are 
present at twice the recommended dose for horses (Erkert and MacAllister, 2002). Additionally, 
isoxsuprine does not increase blood flow to the foot or dorsal laminae of horses (Ingle-Fehr and 
Baxter, 1999). Regardless, horses affected by caudal heel pain and treated with isoxsuprine show 
some improvement in lameness compared to placebo, although the results are better in horses that 
have had clinical signs for less than one year (Erkert and MacAllister, 2002). No adverse side 
effects are reported, even with long term continuous use of the medication (Baxter et al., 2011). 
Clinical use of the drug has decreased in recent years, likely due to the lack of supporting 
evidence for the theory of vascular compromise as the etiopathogenesis of caudal heel pain 
(Erkert and MacAllister, 2002).   
 
2.4.7   Surgical treatments 
 Surgical treatments for caudal heel pain include navicular bursoscopy, navicular 
suspensory ligament desmotomy, and palmar digital neurectomy. Endoscopy of the navicular 
bursa can be used for both diagnosis and treatment. Horses that have navicular bone flexor 
surface abnormalities and dorsal fibrillation of the DDFT at the level of the navicular bone are 
particularly indicated to undergo this treatment, as bursoscopy provides the opportunity for lesion 
debridement and the removal of possible adhesions (Baxter et al., 2011). Smith and Wright 
(2012) reported that 61% of horses returned to some degree of work with improvement in 
lameness following navicular bursoscopy, but that horses with combination injuries of the 
navicular bone and DDFT were less likely to have a successful outcome. The surgery is 
technically difficult, requires general anesthesia, and there is potential for iatrogenic damage to 
the structures surrounding the bursa (Mählmann et al., 2015).  
 Desmotomy of the navicular suspensory ligament involves transection of the collateral 
sesamoidean ligaments, preferably via an arthroscopic approach through the palmar aspect of the 
distal interphalangeal joint (Sampson et al., 2010). This treatment is possibly indicated if a lesion 
within the collateral sesamoidean ligaments is identified on MRI (Baxter et al., 2011). An open 
approach was historically performed and resulted in short term improvement in lameness, but has 
 37 
fallen out of favour as a treatment option due to the inability to transect the multiple attachment 
sites of the CSL (Sampson et al., 2010). 
 Palmar digital neurectomy, while considered a salvage procedure in most instances, is still 
commonly performed for the management of lameness associated with caudal heel pain (Baxter 
et al., 2011). The sensory nerves supplying the heel region are partially removed, resulting in 
desensitization of the foot and alleviation of pain (Maher et al., 2008). A palmar digital 
neurectomy is an accepted palliative treatment option for horses with caudal heel pain if they are 
unresponsive to other treatments (Gutierrez-Nibeyro et al., 2015). It is advised to perform a 
palmar digital nerve block prior to surgery to determine the amount of lameness improvement 
that can be expected. It is suspected that horses with lesions of the DDFT at the level of the 
navicular bone are poor candidates for neurectomy due to an increased risk of tendon rupture 
following the surgery (Baxter et al., 2011). However, there is no peer-reviewed evidence to 
confirm this suspicion. Palmar digital neurectomy can effectively reduce or resolve lameness 
associated with caudal heel pain in 74-92% horses for at least one year following surgery 
(Gutierrez-Nibeyro et al., 2015; Jackman et al., 1993; Maher et al., 2008). Horses with core 
lesions or parasagittal splits in the DDFT may have a decreased prognosis associated with 
residual or early recurring lameness (Gutierrez-Nibeyro et al., 2015). Complications following 
palmar digital neurectomy include: incomplete resolution of lameness, recurrence of lameness 
associated with caudal heel pain due to nerve regrowth, development of a painful neuroma, sepsis 
of the distal phalanx, rupture of the DDFT, luxation of the distal interphalangeal joint, sloughing 
of the hoof capsule, navicular bone fracture and unnoticed severe infection within the foot 
(Baxter et al., 2011; Maher et al., 2008). 
 
2.4.8   Acupuncture 
 Acupuncture is a non-invasive, non-pharmaceutical modality that may reduce pain and 
lameness in horses (Robinson and Manning, 2015). Acupuncture has been shown to modulate 
endorphin release at the level of the spinal cord, and as such, may reduce levels of chronic pain in 
horses (Dunkel et al., 2017). However, multiple studies have failed to prove the usefulness of this 
modality for horses with chronic lameness caused by caudal heel pain (Robinson and Manning, 
2015; Schoonover et al., 2005; Steiss et al., 1989). 
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2.4.9   Experimental treatments 
 Several experimental treatment options have been examined for use in horses with caudal 
heel pain. One group evaluated the response to intra-bursal injection of botulinum toxin type B in 
horses affected with caudal heel pain and found a decrease in lameness at 7 or 14 days after 
injection, although no horses became sound during the study period (Gutierrez-Nibeyro et al., 
2014). A study performed in healthy horses investigated surgical core decompression of the 
navicular bone, and found that following drilling, intraosseous pressure was reduced in the 
navicular bone, and osseous remodeling and neovascularization was present adjacent to the 
surgical sites (Jenner and Kirker-Head, 2011). This may represent a promising treatment option, 
if similar results can be demonstrated in diseased horses. 
 
2.5   Shock Wave Therapy 
 Extracorporeal shock wave therapy was initially developed for dissolution of urinary 
calculi in humans (Chung and Wiley, 2002). Osseous remodeling was noted in the pelvis of 
humans following treatment of the ureter for urolith dissolution (Graff et al., 1987). The therapy 
was then explored as a treatment for musculoskeletal disorders in humans such as non-union 
fractures and insertional desmopathies, and positive results stimulated the use of this therapy in 
other species (McClure and Dorfmüller, 2003). 
 It is suspected that ESWT is used with relative frequency in equine practice, although true 
prevalence of treatment use has not been determined. Anecdotally, the therapy is widely used to 
treat tendon and ligament injuries, epaxial muscle pain, dorsal metacarpal disease, osteoarthritis, 
wounds, and caudal heel pain. 
 
2.5.1   Physics and types  
 Shock waves are generated by a sudden release of energy, creating a pressure wave that 
can propagate rapidly through body tissues (Chung and Wiley, 2002). A quick rising positive 
pressure wave is followed by a longer decrease to normal pressure and a negative pressure wave. 
The pressure difference causes tensile stress and can create cavitations within the tissue (McClure 
and Dorfmüller, 2003). The greatest release of energy at the tissue level occurs when the density 
of two tissues is different, such as at a bone-tendon interface (Leeman et al., 2016).  
 39 
 Shock waves require a fluid medium or tissue through which to propagate, and are 
reflected by air-containing surfaces such as the pleural or intestinal surface (McClure and 
Dorfmüller, 2003). The energy contained in a shock wave is measured in millijoules (mJ). The 
energy supplied to the target tissue can vary. Energy flux density (EFD) is a good way to describe 
the dose of energy applied to a focal point within tissue. This is the amount of energy applied in 
millijoules to one square millimetre (mJ/mm2) (McClure and Dorfmüller, 2003). Research 
typically uses EFD to describe dose used. In human and laboratory animal research, high EFD is 
more than 0.6 mJ/mm2, medium EFD between 0.08 and 0.28 mJ/mm2, and low EFD is less than 
0.08 mJ/mm2 (Rompe et al., 1998). This is important to consider when evaluating research on 
ESWT, as a dose-dependent effect has been noted in some tissues and species (F. S. Wang et al., 
2002).  
 Shock waves are generated by one of four methods: electrohydraulic, electromagnetic, 
piezoelectric, and pneumatic/ballistic (McClure and Dorfmüller, 2003). The first three methods 
produce a very focused shock wave by converting electricity into rapid physical movement. 
These shock waves converge on a small focus point, do not expose the surrounding non-target 
tissues to the therapy, and are able to penetrate tissue to a deeper point. Only the ballistic method 
produces non-focused (or radial) shock waves, which are generated by a projectile moving at 
high speeds. Radial shock waves concuss all tissues, including surrounding non-target tissues, 
uniformly and are not as penetrating as focused shock waves (Chung and Wiley, 2002).  
 
2.5.2   Proposed mechanisms of action 
 Within tissues, shock waves undergo absorption, refraction, reflection and transmission of 
the energy (Ogden et al., 2001). In many body tissues, the tensile stress created by the shock 
wave can cause cell displacement without heating, can transiently alter cell membrane 
permeability and stimulate cytoplasmic organelles and the nucleus (Chung and Wiley, 2002; 
Romeo et al., 2013). This may result in nitric oxide and growth factor production, resulting in 
activation of further biologic processes, depending on the type of cell stimulated (Romeo et al., 
2013; C. J. Wang et al., 2002; Wang et al., 2009). Nitric oxide can have an anti-inflammatory 
effect, which may contribute to pain reduction (van den Boom et al., 2005). However, ESWT 
may stimulate local inflammation in the treated tissues as well. Wang et al. (2002) determined 
that high-energy ESWT caused hemorrhage and inflammation when the femoral artery and nerve 
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were treated in dogs. The pattern and timeline of anti-inflammatory and inflammatory effects has 
not yet been completely determined through research. There may also be a dose-dependent effect 
on tissue response (Rompe et al., 1998; F. S. Wang et al., 2002), and it is possible that different 
tissue structures and types respond to the therapy in a different way. Structural alignment of 
tissues such as collagen may be reversibly disrupted (Cárcamo et al., 2012) and in this way, 
focused ESWT may improve healing of osseous and soft tissue structures (F. S. Wang et al., 
2002). Mechanisms of action that may support improved healing at the tissue level include 
induction of neovascularization (Kersh et al., 2006; C. J. Wang et al., 2002), increased expression 
of growth factors such as transforming growth factor-beta-1 (TGF-b1)  (Caminoto et al., 2005), 
and increased cellular metabolism, glycosaminoglycan levels and protein synthesis (Bosch et al., 
2007). 
 
2.5.3   Effects on tissues 
 
2.5.3.1   Effects on osseous tissues 
 The effects of ESWT on osseous tissues in horses and other species have been 
investigated at the cellular and macroscopic levels. Low energy ESWT induced a cyto-
stimulatory response in human osteoprogenitor cell lines through increased production of nitric 
oxide, osteocalcin and TGF-b1 (Martini et al., 2003). Induction of TGF-b1production was also 
noted in association with an enhanced formation of bone nodules in an in vitro study in rats (F. S. 
Wang et al., 2002). The osteogenic effect of ESWT may be dose dependent. In rabbits, a higher 
dose of shock waves applied to bone caused fractures and aseptic necrosis, but a lower dose 
stimulated osteogenesis with minimal cell damage (Haupt, 1997).  
 In horses, an increase in TGF-b1 has not been investigated in osseous tissues following 
ESWT, although this effect has been noted in experimentally induced suspensory ligament 
desmitis treated with ESWT (Caminoto et al., 2005). Results in equine bone are somewhat 
contradictory, and it is suspected that ESWT induces osseous remodeling due to the formation of 
microcracks. One group has demonstrated osteogenic stimulation and an endosteal response 
following ESWT applied to the third metacarpus/metatarsus (McClure et al., 2004b). Another 
group determined that focused ESWT increased microfracture density in cortical bone, but 
ballistic/radial ESWT increased microfracture length (Da Costa Gómez et al., 2004). Yet another 
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study found that neither method of ESWT application caused microcracking in cortical bone 
(Pauwels et al., 2004). Histologic investigation following treatment of the proximal suspensory 
region (bone-ligament interface) in horses revealed no microfractures but increased density of 
osteoblasts in treated regions compared to control limbs (Bischofberger et al., 2006). These 
varied results may be due to a lack of consistency in treatment protocol or type of ESWT used, 
and in vivo versus in vitro studies.  
 Clinical studies in humans have shown a benefit of ESWT for delayed union and non-
union fractures (Schaden et al., 2001). It is unknown if ESWT truly has a regenerative effect in 
horses, or what is an ideal treatment protocol for specific conditions. Ballistic/radial ESWT has 
been found to be an effective adjunctive treatment for dorsal metacarpal disease (stress fractures) 
that allows Thoroughbred horses to return to speed work and racing sooner than other treatment 
modalities, however, this was investigated without the use of a control group (Palmer, 2002). To 
the author's knowledge, no further research into the osseous effects of ESWT in horses have been 
published. 
 
2.5.3.2   Effects on tendons and ligaments 
 Effects of ESWT on equine tendons and ligaments have been investigated in multiple 
research studies. When applied to normal equine tendons, focused ESWT has been shown to 
cause disorganization of tendon structure (Bosch et al., 2009). Disruption of tissue structure may 
stimulate healing in cases of injury, but caution should be exercised to avoid targeting normal 
tissues. The response of experimentally induced lesions to ESWT has been evaluated. Caminoto 
et al. (2005) determined that expression of TGF-b1 is increased following ESWT applied to 
collagen-induced suspensory ligament desmitis. Additionally, treated limbs had an increased 
number of small, newly formed collagen fibrils and increased numbers of mitochondria present 
compared to control limbs, indicating an increased rate of tissue repair. A similar study showed 
an increased rate of ultrasonographically apparent healing in treated suspensory ligaments versus 
controls (McClure et al., 2004c). Increased neovascularization was noted on histology following 
treatment with ESWT in collagen-induced superficial digital flexor tendon lesions, when 
compared to control limbs (Kersh et al., 2006). Contrarily, collagen induced lesions of the 
accessory ligament of the deep digital flexor tendon did not respond favourably to treatment with 
ESWT, and no significant differences were found in lesion size, echogenicity, or fiber pattern on 
 42 
ultrasound examination, nor on histological examination between treatment and control groups 
(Waguespack et al., 2011). 
 Shock wave therapy may decrease lameness and improve outcomes in horses with 
naturally occurring tendinopathy and desmopathy. Crowe et al. (2004) evaluated the effects of 
radial/ballistic ESWT on horses with suspensory ligament desmitis, and found that more horses 
were able to return to work when compared to previous retrospective studies evaluating 
controlled exercise alone. Further work is required to determine the effects of focused ESWT on 
naturally occurring tendon and ligament injuries. 
 
2.5.3.3   Effects on joints and synovial structures 
 ESWT has been investigated as a treatment modality for osteoarthritis. Seventy-four 
horses with naturally occurring tarsal osteoarthritis were treated with ESWT resulting in an 80% 
improvement in lameness 90 days after treatment, although no change was noted on post-
treatment radiographs, and control horses were not used in the study (McCarroll and McClure, 
2000). Frisbie et al. (2009) determined that focused ESWT improved lameness scores when 
compared to controls in an experimental carpal osteoarthritis model, but could not identify any 
disease-modifying effects in synovial fluid, membranes, or cartilage. Kawcak et al. (2011) further 
evaluated the effect of ESWT on subchondral bone and serum biomarkers in the same carpal 
osteoarthritis model. No change was noted in subchondral bone, but serum osteocalcin 
concentration increased in treated horses, indicating induction of bone remodeling. In a knee 
osteoarthritis model in rats, ESWT application to the medial tibial condyle resulted in a 
regression of osteoarthritis radiographically and histologically, as well as an improvement in 
bone strength in comparison to the control group (Wang et al., 2013). A clinical trial performed 
in humans demonstrated that ESWT using an EFD of 0.093 mJ/mm2 resulted in significantly 
greater improvement in pain scores and functional outcomes when compared to patients receiving 
ESWT at a lower EFD of 0.040 mJ/mm2 (Kim et al., 2015).  
 
2.5.3.4   Analgesic effects 
 Focused ESWT has been shown to cause analgesia in equine musculoskeletal tissues 
(Dahlberg et al., 2006; Frisbie et al., 2009; McCarroll and McClure, 2000; Palmer, 2002), but the 
mechanism of action is somewhat undetermined. Sensory nerve conduction velocity in the 
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palmar digital nerves of equine forelimbs was shown to be decreased following treatment with 
radial/ballistic ESWT due to disruption of the myelin sheath in medium to large diameter 
myelinated axons (Bolt et al., 2004b). However, a study performed in horses has established no 
analgesia of the sensory region after treating the palmar digital nerve with focused ESWT 
(McClure et al., 2005). In the same study, a short-lived local cutaneous analgesic effect was 
identified, unrelated to the sensory region supplied by the nerve. This group established that 
perineural inflammation occurred after treatment using histology, but nerve integrity and 
neuropeptide concentrations did not change. High energy shock waves applied to the femoral 
nerve of dogs caused nerve fiber swelling and damage to the perineural tissues, although no 
evidence of nerve bundle disruption or change in cellular distribution within the nerve was noted 
(C. J. Wang et al., 2002). Damage to the nerve does not equate to an analgesic effect, and this 
canine study did not evaluate nociception. Abed et al. (2007) found that neither focused nor 
radial/ballistic ESWT depleted the neuropeptides substance P or calcitonin gene-related peptide 
in the skin or periosteum of sheep. Additionally, when low-energy ESWT was applied to the 
spinal cord of rats, the expression of substance P and calcitonin gene-related peptide did not 
change, indicating that ESWT likely does not stimulate the endogenous pain control system 
through hyperstimulation (Haake et al., 2002). The anti-nociceptive or analgesic effect of ESWT 
remains speculative.  
 
2.5.4   Use and efficacy for caudal heel pain  
 A definitive but transient analgesic effect was noted by Dahlberg et al. (2006) when 
focused ESWT was used to treat horses with caudal heel pain, and McClure et al. (2004a) 
identified an analgesic effect in 81% of horses with caudal heel pain six months following 
treatment with focused ESWT. A similar analgesic effect resulting in a reduction in lameness has 
been identified by Blum (2004) and Bår et al. (2001). However, all of these studies were 
performed without control groups or blinding of the investigators, and an effect of the therapy 
was not noted radiographically (McClure et al., 2004a). MRI was not used for diagnosis or 
monitoring in any of these studies. Radial ESWT has not been shown to provide analgesia nor 
have any effect on nuclear scintigraphy results for horses with navicular syndrome (Brown et al., 
2005; Byron et al., 2009). To the author's knowledge, disease modifying effects of ESWT have 
not been identified for caudal heel pain in horses.  
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2.5.5   Adverse effects 
 Adverse effects of ESWT depend on the tissues targeted and the energy dosage used. 
Subperiosteal and endosteal hemorrhage has been identified in equine bone (McClure et al., 
2004b). At high energy levels, cell death may occur (Martini et al., 2003), and local hemorrhage 
and inflammation was noted in blood vessels (C. J. Wang et al., 2002). Further adverse effects 
may include pain during and/or intolerance of treatment administration, increase in lameness 
following treatment, or microcracking of bone (Da Costa Gómez et al., 2004; Revenaugh, 2005).  
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3.  SPECIFIC AIMS 
 
The specific aims of this thesis are: 
 
To characterize the use of ESWT among equine practitioners in North America (Chapter 4). 
To determine the analgesic efficacy (via measurement of lameness and kinematic gait analysis) of 
focused ESWT on horses with naturally occurring caudal heel pain (Chapter 5). 
To determine the effect of focused ESWT on the appearance of lesions diagnosed by MRI in 
horses with naturally occurring caudal heel pain (Chapter 5).   
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CHAPTER 4 
 
Transition Page 
 
Characterization of the use of shock wave therapy among equine practitioners 
 
This chapter utilized an online survey to determine the frequency and type of ESWT use among 
equine practitioners registered with the AAEP. 
 
Copyright statement: Submission of Chapter 4 for publication is impending. The copyright of 
this Chapter will belong to the journal in which it is published. The full citation will be available 
upon publication. 
 
Author Contribution: MacKay and Robinson were responsible for the experimental design. 
MacKay, McOnie, and Riddell were responsible for data collection and organization. MacKay 
was responsible for data analysis. MacKay, McOnie, Riddell, and Robinson wrote the 
manuscript.  
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4. Characterization of the use of shock wave therapy among equine practitioners 
Angela V. MacKay, Rebecca C. McOnie, Lea P. Riddell, Katherine A. Robinson 
 
4.1 Abstract 
 The use of extracorporeal shock wave therapy (ESWT) has increased in both veterinary 
and human medicine. Research to date has prioritized mechanism of action and efficacy of the 
therapy; data regarding clinical use patterns is not available. The objective of this survey was to 
characterize the use of ESWT by equine practitioners specifically regarding rate of use, 
indications for use, and opinion of efficacy and tolerability. A 21-question survey was offered 
using an online survey engine to all 7787 members of the American Association of Equine 
Practitioners (AAEP) between April 25 and June 6, 2016. One-hundred-and-forty-four responses 
were obtained. ESWT was used frequently by 65/144 (45.1%) respondents, infrequently by 
61/144 (42.4%) respondents, and never by 18/144 (12.5%) respondents. The most common 
reason for use was to treat ligamentous injuries. Overall, the therapy was rated as a moderately 
effective option for various musculoskeletal conditions of the horse. Respondents who do not use 
the therapy indicate a lack of scientific evidence supporting its use and a lack of access to the 
technology as contributing factors. The information gained from this survey will help direct 
further research and development, and may guide practitioners’ use of ESWT.  
 
4.2 Introduction 
 Shock wave therapy (extracorporeal shock wave therapy, ESWT) has become 
increasingly common in human and veterinary medicine. Originally developed for dissolution of 
urinary calculi in humans, ESWT has evolved into a treatment modality for musculoskeletal 
injuries in animals and humans. Research has concentrated on the mechanism of action of ESWT 
and treatment efficacy for both experimentally induced and naturally occurring musculoskeletal 
disease processes in rats, sheep, dogs, horses and humans (Chung and Wiley, 2002; Leeman et 
al., 2016; McClure et al., 2005; Wang et al., 2013).  
 Types of ESWT generators, treatment protocols, indications for use, and evidence and 
definition of efficacy vary in the scientific literature (Chung and Wiley, 2002; McClure and 
Dorfmüller, 2003). Data regarding the use of ESWT in equine veterinary clinical practice has not 
been available. The goal of this study was to characterize the use of ESWT among equine 
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veterinary practitioners regarding: rate of therapy use, diseases treated, and clinical opinion of 
treatment efficacy and tolerability. We hypothesized that ESWT was commonly used by equine 
veterinary practitioners, and that clinicians would rate ESWT as a well-tolerated and effective 
treatment for a variety of musculoskeletal conditions in the horse.  
 
4.3 Materials and Methods 
 
4.3.1 Sample and survey 
 A 21-question survey was offered to the 7787 members of the American Association of 
Equine Practitioners (AAEP). Contact was initiated electronically via email; a link for a web-
baseda survey was sent. The survey was available for a 6-week period between April 25 and June 
6, 2016, and email reminders were circulated 1 and 3 weeks after survey release. Respondents 
could choose to remain anonymous when completing the survey, and could exit the survey at any 
time. A reward was not offered for survey participation. Question type included multiple choice, 
multiple answer, rating scales, and short answer (Appendix A). Frequency of shock wave use, 
machine type, conditions treated, combinations with other therapies, clinical opinion of the 
therapy, use of sedation, opinion of therapy tolerance, and practice demographics were evaluated. 
Demographic information evaluated included: type of practice worked in, percentage of equine 
work performed by the practice, any complementary therapies offered by the practice, and types 
of horses worked on grouped by discipline. 
 
4.3.2 Statistical analysis 
 All surveys were reviewed for completion and errors once received. All available 
responses for each question were included in the analysis. Numerical data was tested for 
normality of distribution using Shapiro-Wilks test for normality. Responses were summarized, 
and percentages were calculated for all questions. Data were examined for number of responses 
per question option, and then re-categorized based on response distribution if indicated to 
facilitate statistical analysis. For questions regarding self-reported rate of use, the responses were 
grouped into categorical ranges if not normally distributed: rarely or never (0-20%), seldom (21-
40%), about half the time (41-60%), often (61-80%), and almost always or always (81-100%). 
Reporting the percentage of horse work in the veterinary practice was exempted from the above 
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categorization; responses to this question were grouped into one of 2 categories: 100% equine 
work (equine-only), or all other responses (not equine-only). 
 Associations were assessed using Fisher’s Exact test for binary outcome variables and 
Kruskal-Wallis test for continuous and categorical scale outcome variables. A Bonferroni 
correction was used to control overall experimental error for multiple pairwise comparisons. 
Predictors included practice type, amount of equine work, and if complementary therapies were 
offered by the practice. The outcome variable examined included frequency of ESWT use. 
Further associations were examined between frequency of ESWT use and opinion of efficacy, as 
well as use of sedation and opinion of tolerance. Statistical analysis was performed using 
statistical softwareb. Significance was set at p <0.05. 
 
4.4 Results 
 One-hundred-and-forty-four (144/7787) survey responses were collected (1.8% response 
rate). Thirteen surveys were incomplete; available responses for individual questions from 
incomplete surveys were included in the analysis. The data were not normally distributed.  
 
4.4.1 Demographic information 
 Most respondents indicated that their practice was equine-only (108/131; 82.4%). 
Twenty-three of 131 respondents (17.6%) indicated that their practice was not equine-only. 
Respondents were asked what type of practice they worked in, such as ambulatory equine, mixed 
practice, racetrack and horse-show practice, or other. Based on distribution, responses were re-
categorized into 4 distinct types of practice. Sixty of 131 (45.8%) respondents were in a general 
or ambulatory equine practice. Twenty-two of 131 (16.8%) were part of a specialist or referral 
equine practice, including surgery, radiology, or sports medicine. Forty of 131 (30.5%) 
respondents were part of a racetrack (flat or harness) or show horse-based practice. Nine of 131 
respondents worked in a mixed practice (6.9%). Types of horses seen were divided by generic 
discipline, and respondents could select all that applied. English performance horses were the 
most common type of horses seen (103/131, 78.63%), followed by companion or pleasure horses 
(86/131, 65.65%) and Western performance horses (77/131, 58.78%). Complementary therapy 
offerings were investigated; 39/131 (29.8%) respondents did not offer complementary therapies 
to their clients. Many respondents offered more than one type of complementary therapy, with 
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the most common types being acupuncture (69/131, 52.67%), chiropractic (53/131, 40.46%), and 
therapeutic laser (42/131, 32.06%).  
 
4.4.2 Frequency of shock wave therapy use 
 To determine the rate of use of ESWT, respondents were given five descriptive options 
including: daily, at least once per week, at least once per month, less than once per month, and 
never. Based on response distribution, these data were re-categorized for analysis into frequently 
(daily, once per week), infrequently (once per month, less than once per month), and never. 
Sixty-five of 144 (45.1%) respondents indicated that they use ESWT frequently in their practice. 
Sixty-one of 144 (42.4%) respondents indicated that they use ESWT infrequently. Only 18/144 
(12.5%) respondents indicated that ESWT was a modality that they never use in their practice. 
Respondents who do not use ESWT indicated that a lack of scientific evidence supporting its use 
and a lack of access to the technology were their primary reasons. ESWT was more likely to be 
used if the practice was 100% equine (p = 0.018) and if complementary therapies were also 
offered by the veterinarian (p = 0.02). The rate of ESWT use was different (Kruskal-Wallis test, 
X2 (3) = 22.282, p = 0.0001) between mixed practice (n=9), general and ambulatory equine 
(n=60), referral equine (n=22), and sport horse/racetrack practice (n=40). Referral equine had a 
higher rate of use than mixed practice (p = 0.0029) and general equine practice (p = 0.0073). 
Sport horse/racetrack practice had a higher rate of use than both mixed practice (p = 0.0004) and 
general equine practice (p=0.0005). Referral equine and sport horse practice did not differ (p = 
0.95); nor did mixed practice or general equine practice (p = 0.0576). A Bonferroni correction 
was used to control overall experimental error for multiple pairwise comparisons; comparisons 
following the correction were considered significant at p<0.008.  
 Respondents were asked how often they chose ESWT as a single treatment modality. 
Forty-one of 120 (34.2%) respondents rarely or never used the therapy as the single treatment for 
an injury (Table 4.1). Only 9/120 (7.5%) respondents almost always or always used ESWT as the 
single treatment modality. In a separate but related question, respondents were asked how often 
they used ESWT as part of a multi-modal treatment plan, or in conjunction with other treatments 
for an injury. Twenty of 120 (16.7%) respondents almost always or always use the therapy in 
conjunction with other treatment options for an injury (Table 4.1). Twenty-seven out of 120 
(22.5%) respondents rarely or never use ESWT in conjunction with other treatment options. 
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Thirty-three out of 120 (27.5%) respondents to both questions regarding rate of use did not sum 
their responses to ensure equal but opposite responses. Characterization of multi-modal use of the 
therapy was requested. Most respondents (110/118, 93.2%) indicated that they prefer to use 
ESWT in conjunction with other medically appropriate therapies, depending on the injury. 
Twenty-one of 118 (17.8%) respondents indicated that ESWT was preferred in situations where 
more advanced therapies would not be financially feasible.  
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Table 4.1  Number and percent of respondents who reported using ESWT as a single treatment 
and as part of a multi-modal treatment approach for musculoskeletal injuries (120 respondents for 
each question). 
 
 
Single Treatment Approach  
# (%) 
Multi-Modal Approach  
# (%) 
Rarely or Never 41 (34.2) 27 (22.5) 
Seldom 17 (14.2) 21 (17.5) 
About Half the Time 27 (22.5) 29 (24.2) 
Often 26 (21.6) 23 (19.2) 
Almost Always or Always 9 (7.5) 20 (16.6) 
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4.4.3 Method of shock wave therapy use   
 Respondents were asked what brand(s) of shock wave machine(s) they used in practice to 
determine which types of shock wave generators were being used. The brands of shock wave 
machines were re-categorized into focused, radial, or dual (focused and radial) machines based 
on information freely available from the manufacturers. Ninety-two of 125 (73.6%) respondents 
used a focused-type machine, including but not limited to the Versatron® (Pulse Veterinary 
Technologies, LLC, Alpharetta, Georgia), VetGold® (Tissue Regeneration Technologies, LLC, 
Woodstock, Georgia), and NeoVet® (Nucleus Regenerative Therapies, Kennesaw, Georgia). 
Seventeen out of 125 (13.6%) respondents used a radial-type machine, including but not limited 
to Storz Masterpuls MP200 (Storz Medical AG, Tägerwilen, Switzerland). Six of 125 (4.8%) 
respondents used both types of machines, or a dual machine such as the Storz Duolith (Storz 
Medical AG, Tägerwilen, Switzerland).  
 The condition that was most commonly treated with ESWT was desmitis, treated by 
118/125 (94.4%) respondents. Tendon injuries were treated using the therapy by 96/125 (76.8%) 
respondents, muscle pain was treated by 79/125 (63.2%), osteoarthritis was treated by 64/125 
(51.2%), and navicular syndrome was treated by 34/125 (27.2%) respondents. Other responses 
for indications for ESWT use included: wounds, proximal sesamoiditis, non-healing fractures, 
periostitis of the third metacarpal bone, sacroiliac pain, generalized back pain, sclerosis of the 
third carpal bone, cervical vertebral pain, injury to the second and fourth metacarpal or tarsal 
bones, and digital cushion pain. 
 Sedation was always used to administer ESWT to horses by 50% (59/118) of respondents. 
Of the 50% that do not always use sedation for ESWT administration, 16/59 (27%) rarely or 
never used sedation to administer ESWT; of those 16 respondents, 3 respondents indicated that 
they never used sedation to administer the therapy. 
 Protocols for use may be included with the specific ESWT machine. When provided by 
the manufacturer, these given protocols were followed about half of the time by 24/118 (20.34%) 
respondents, often followed by 33/118 (27.97%) respondents, and almost always or always 
followed by 28/118 (23.73%) respondents. However, the protocols were rarely or never followed 
by 27/118 (22.88%) of respondents. 
 Respondents were asked to rate their clinical opinion of how well equine patients tolerate 
application of ESWT to various body regions on a scale of 1-4, with 1 being intolerable and 4 
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being completely tolerable. Most respondents indicated that equine patients were moderately to 
completely tolerable of ESWT, regardless of the body region (Table 4.2). Opinion of tolerance 
was not associated with the use of sedation to administer the therapy to the joints of the distal 
limb (p = 0.3), the flexor tendons (p = 0.4), the foot and heel region (p = 0.3), the hock joints (p = 
0.3), or the epaxial muscles (p = 0.1). 
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Table 4.2 Respondents’ clinical opinion of patient tolerance for ESWT applied to specified body 
regions. Results are shown as number and percent of respondents per rating category (131 
respondents for the question). 
 
 Intolerable  
# (%) 
Moderately 
Intolerable  
# (%) 
Moderately 
Tolerable  
# (%) 
Complete 
Tolerance  
# (%) 
Not Applicable  
# (%) 
Distal 
limb joints 
5 (3.8) 33 (25.2) 44 (33.6) 32 (24.4) 17 (13.0) 
Flexor 
tendons 
0 (0) 11 (8.4) 59 (45.1) 51 (38.9) 10 (7.6) 
Foot/heels 0 (0) 18 (13.7) 45 (34.3) 34 (26.0) 34 (26.0) 
Hocks 5 (3.8) 32 (24.4) 36 (27.5) 27 (20.6) 31 (23.7) 
Epaxial 
muscles 
1 (0.8) 7 (5.3) 38 (29.0) 69 (52.7) 16 (12.2) 
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 To rate their opinion of the efficacy of ESWT as a single treatment option for various 
musculoskeletal disorders, respondents were given a scale of 1-5, with 1 being completely 
ineffective and 5 being highly effective. Based on a clustered response distribution, this scale was 
condensed into a 3 point descriptive scale for analysis: ineffective (ratings 1 and 2), somewhat 
effective (rating 3), and highly effective (ratings 4 and 5). ESWT was viewed as a highly 
effective treatment option for ligament injuries and muscle pain management; a somewhat 
effective treatment option for tendon injuries; and an ineffective treatment option for 
osteoarthritis pain management and navicular syndrome (Table 4.3). There was no association 
between frequency of ESWT use and opinion of efficacy for osteoarthritis pain management (p = 
0.617), flexor tendinitis (p = 0.178), desmitis (p = 0.086), navicular syndrome (p = 0.65), or 
muscle pain management (p = 0.087). 
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Table 4.3 Respondents’ clinical opinion of ESWT efficacy for specified musculoskeletal 
disorders. Results are shown as number and percent of respondents per rating category (133 
respondents for the question). 
 
 
Ineffective 
# (%) 
Somewhat 
Effective 
# (%) 
Completely 
Effective 
# (%) 
OA Pain Management 63 (47.4) 43 (32.3) 27 (20.3) 
Tendon Injuries 38 (28.6) 44 (33.1) 51 (38.3) 
Ligament Injuries 20 (15.0) 36 (27.1) 77 (57.9) 
Navicular Syndrome 78 (58.6) 36 (27.1) 19 (14.3) 
Muscle Pain Management 32 (24.1) 39 (29.3) 62 (46.6) 
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4.5 Discussion 
 Objective information regarding ESWT use among equine practitioners was previously 
not available. This survey outlines the use and perceived effectiveness of ESWT in the equine 
veterinary field.  
 Although commonly used in equine veterinary practice, there is conflicting evidence 
supporting the use of ESWT. Multiple studies have shown that treatment with ESWT alleviated 
pain and lameness in horses, regardless of the disease process (Dahlberg et al., 2006; Frisbie et 
al., 2009; McCarroll and McClure, 2000; Palmer, 2002). In vivo work in horses has demonstrated 
changes to sensory nerve conduction following ESWT that could explain an analgesic effect 
(Bolt et al., 2004b). As such, regulations have been established in some equine competitive 
jurisdictions to prevent ESWT use immediately prior to competition. However, work performed 
in horses with chronic forelimb lameness shows no change in force plate analysis of gait 
immediately following treatment with radial ESWT (Brown et al., 2005). A separate study 
performed in horses established that there was no analgesia of the cutaneous nerve field when the 
palmar digital nerve was treated with ESWT, but a local cutaneous analgesic effect was produced 
(McClure et al., 2005). The same group evaluated histological changes after ESWT was applied 
to a subcutaneous nerve in sheep, and demonstrated perineural inflammation but no changes in 
nerve integrity or neuropeptide concentrations (McClure et al., 2005). The effects of ESWT on 
bone, tendon, and ligaments have been examined. A positive effect of ESWT at the tissue level 
has been noted in multiple species, including an anti-inflammatory effect (Mariotto et al., 2009), 
induction of neovascularization (Kersh et al., 2006; C. J. Wang et al., 2002), increased expression 
of transforming growth factor - beta 1 (TGF-β1) (Caminoto et al., 2005), and transient increased 
cellular metabolism, glycosaminoglycan levels and protein synthesis (Bosch et al., 2007) when 
compared to controls, indicating possible mechanisms for improved healing in osseous and 
connective tissue structures. It has been shown that the effects on osseous structures are dose-
dependent, with lower energy doses stimulating osteogenesis and high energy doses causing 
microfractures, aseptic necrosis and damaged osteocytes (F. S. Wang et al., 2002). Despite this 
information, optimal dosage ranges for specific injuries in horses have not been established. In 
addition, a study reporting decreased lameness was not able to demonstrate any disease 
modifying effects when ESWT was used to treat experimentally induced osteoarthritis (Frisbie et 
al., 2009), and another group has reported a lack of improved healing when ESWT was used to 
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treat experimentally induced desmitis (Waguespack et al., 2011). Difficulties exist in 
interpretation of the current literature and are beyond the scope of this paper, in part because the 
studies are widely varied in terms of design, use of appropriate blinding and negative controls, 
and sample size. The available evidence has not yet provided a long-term assessment of the 
effects of ESWT in horses, so it is not known if the treatment improves the final outcome for 
musculoskeletal injuries compared to negative controls or other available treatments. 
 Rate of ESWT use as either a single therapy or as part of a multi-modal treatment plan 
was self-reported by respondents in percentage format. These questions were asked in 
conjunction, but respondents were not explicitly directed to ensure logical summation of their 
responses (to 100%). As stated above, 27.5% of respondents did not provide equal and opposite 
responses. Categorization of the percentage data resulted in apparent illogical responses, as 
represented in Table 4.1. It is possible that some respondents did not consider that a single 
therapy plan is the opposite of a multi-modal therapy plan. The lack of explicit direction was 
intended to allow respondents to convey their own opinions and uses of ESWT. However, this 
created discordant results and represents a weakness of the survey design. 
 The current survey established that veterinary practitioners have a moderately positive 
view regarding the efficacy of ESWT for treating various injuries in horses. However, 
respondents were simply asked to provide a rating; a definition of efficacy was not provided or 
allowed to be stated by the respondent. Efficacy could have been interpreted by respondents in 
multiple ways. For example, one practitioner could have deemed ESWT to be efficacious in 
treating osteoarthritis if the patient’s lameness was alleviated with no change in radiographic 
evidence of disease. Another practitioner could conclude that ESWT was efficacious in treating a 
tendinopathy based on improvement in ultrasonographic appearance on recheck examination 
regardless of the degree of lameness improvement. In this way, the survey was a tool to examine 
practitioner use and opinion of ESWT and provides a starting point for more precise 
investigations. However, this lack of a definition of efficacy as used in this survey may not have 
allowed for an accurate evaluation of respondents’ opinions; it simply provided an estimate. This 
highlights the need to provide defined, concrete end-points in both surveys and in equine 
scientific literature.  
 The current survey also established that veterinary practitioners consider ESWT a 
moderately to completely tolerable therapy for their equine patients, based on a rating scale. This 
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question was not asked in relation to the use of sedation to administer ESWT, and a definition of 
tolerable was not provided nor allowed to be stated by the respondent. As discussed for efficacy, 
tolerable could have different meaning for each respondent. Again, this lack of a definition did 
not allow an accurate or complete evaluation of respondents’ opinions. This possibility for 
widespread interpretation represents a limitation of the current study. 
 The poor survey response rate (1.8%) and undetermined possible biases were important 
limitations of this study. A previous survey of a similar population elicited 831 responses, or a 
7.6% response rate (Ferris et al., 2011). The pool of respondents was limited to those with access 
to email and internet. In addition, voluntary surveys can produce non-response bias, which poses 
a significant risk to the accuracy of the results, given the possibility that the responses of the 
respondents could differ from those that would be provided by non-respondents (Dargatz and 
Hill, 1996). In this survey, ESWT users may have been more likely to voluntarily complete the 
survey. However, based on demographic responses, our population was similar to that of a 
previous survey investigating intra-articular injection practices of equine veterinarians. Ferris et 
al. (2011) reported that 80.3% of their respondents worked in a practice that saw 100% equine 
cases. This is similar to our result of 82.4%. This indicates that our population of respondents 
may be representative of the entire population sampled. However, the AAEP published 
demographic information for the year the survey was available stating that 45.4% of their 7787 
members worked in a practice that saw 100% equine cases1, indicating that non-response bias 
could be present. It is possible that non-response bias existed both due to the conflicting scientific 
evidence supporting ESWT, and due to the interests of equine-only practitioners. Both the subject 
of the current survey and the previous survey of the same population were more likely to be of 
interest to veterinarians who were equine-only practitioners. 
 The current survey attempted to gather a large volume of information regarding ESWT 
use and had a small number of respondents. Further work on this topic should attempt to improve 
response rate and decrease potential non-response bias. Methods to achieve this include mailing 
out surveys, conducting phone surveys, offering a small reward for survey completion, 
decreasing the length of the survey, increasing the duration that the survey is available, or 
establishing the statistical difference between responses of early and late respondents to estimate 
the amount of sampling bias (Hutchison et al., 1987; Sax et al., 2003). Information that would 
improve the available body of literature regarding ESWT include therapy protocols used for 
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defined injuries (including frequency, dose and duration of therapy), type of ESWT generator 
used, and specific outcome measures being used to indicate treatment success. Expanding the 
survey population to a wider range of veterinarians may improve response rate. Widening the 
survey topic to include other species may result in a more accurate assessment of ESWT use by 
the entire veterinary population. 
 In conclusion, shock wave therapy was commonly used by the equine practitioners who 
participated in this survey. The therapy was used to treat a diverse range of injuries in the horse. 
Clinical opinion of the efficacy of the therapy was variable and depended on the condition being 
treated. Practitioners indicated that they considered ESWT to be moderately well to completely 
tolerated by their patients. Practitioners who have an equine-only practice were more likely to use 
ESWT than those who worked in mixed practice. Non-response bias likely affected the results of 
this survey. Further work should include efforts to reduce non-response bias or to select a 
representative sample. Future surveys of practitioners regarding shock wave therapy should focus 
on the clinical use of the technology. 
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4.6 Footnotes 
 
1.  American Association of Equine Practitioners Annual Report 2016 (2017). aaep.org Accessed 
November 2017. 
 
a.  Survey Monkey; surveymonkey.com, Portland, OR 
b.  Stata®, StataCorp LP, College Station, TX.  
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A NOVEL APPROACH TO THE TREATMENT OF CAUDAL HEEL PAIN IN HORSES 
USING EXTRACORPOREAL SHOCK WAVE THERAPY 
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A novel approach to the treatment of caudal heel pain in horses using extracorporeal shock 
wave therapy 
 
This chapter evaluated the effects of ESWT for treatment of naturally occurring caudal heel pain 
via subjective lameness evaluation, kinematic gait analysis, and magnetic resonance imaging. 
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5.  A novel approach to the treatment of caudal heel pain in horses using extracorporeal 
shock wave therapy 
MacKay, AV; Manning, ST; McOnie, RC; Riddell, LP; Werpy, NM; Robinson, KA 
 
5.1 Abstract 
Caudal heel pain is a common cause of forelimb lameness in the horse (Sampson et al., 2009). 
Multiple treatment options are available, including: therapeutic farrier work, systemic anti-
inflammatories, intra-articular or intra-bursal medication, systemic bisphosphonates, and 
vasoactive medications (Barrett et al., 2017; Bell et al., 2009; Denoix et al., 2003; Schoonover et 
al., 2005), but none have demonstrated a clear disease-modifying effect or have been evaluated 
using magnetic resonance imaging (MRI). Extracorporeal shock wave therapy (ESWT) has been 
shown to reduce pain and lameness associated with caudal heel pain (Dahlberg et al., 2006; 
McClure et al., 2004a). The current study evaluated the effects of focused ESWT on the degree of 
lameness using subjective assessment and kinematic gait analysis, as well as the change in 
lesions over time as diagnosed by MRI in horses with naturally occurring caudal heel pain. This 
was a randomized, double-blind, controlled trial in horses with naturally occurring caudal heel 
pain undertaken between June 2015 and August 2017. Thirty adult horses underwent a lameness 
exam, diagnostic analgesia of the lame limb(s), kinematic gait analysis, radiographs, and MRI of 
both front feet to diagnose caudal heel pain and determine inclusion at day -16. Horses were 
randomized into the treatment group (n=15) or the control group (n=15). Focused ESWT (1,500 
shock waves, energy flux density of 0.28 mJ/mm2 at 360 Hz, penetration depth of 35 mm) was 
applied to the heel bulb region of affected limbs with standing sedation on days 0, 14, and 28 to 
horses in the treatment group; standing sedation but no ESWT was administered to the control 
group on days 0, 14, and 28. A lameness exam and kinematic gait analysis was performed at each 
treatment point before sedation. At day 128, the inclusion procedures as listed above were 
repeated. Outcome measures included: change in subjective lameness grade (0-5/5) of each limb, 
total subjective lameness score (0-10/10) of each horse, absolute change in kinematic gait 
analysis measures, and change in MRI grades for each included limb from day -16 to day 128. 
Forty-nine limbs (11 unilateral, 19 bilateral; 30 horses total) were evaluated. The median 
decrease in lameness grade per limb was 1 grade between day -16 and day 128; groups were not 
significantly different. The median total lameness score per horse at baseline was 5/10 units. The 
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median change in total horse lameness score was -1 unit (interquartile range, IQR: -2 to 0 units) 
for the control group and -2 units (IQR: -3 to -1 units) for the treatment group (p=0.15). If only 
unilaterally lame horses (n = 11) were considered, the control group (n=7) experienced no change 
in total lameness score (a median change of 0 lameness units; IQR: -1 to 1 units) and the 
treatment group (n=4) experienced a significantly different median decrease of 1 lameness units 
(IQR: -2 to -1 units) (p=0.049). Kinematic gait analysis results were not validated for use with 
bilaterally lame horses, so only results from unilaterally lame horses were reported. Horses in the 
treatment group had a larger degree of decrease in some kinematic parameters than those in the 
control group following treatment, although no statistically significant differences were found. 
When change in MRI grades were compared between groups, the control group exhibited 
improved navicular bursitis and the treatment group exhibited worsened navicular bursitis 
(p=0.027). No other significant differences were found. Focused ESWT may decrease 
subjectively assessed pain in horses with unilateral caudal heel pain for at least 128 days. 
However, the therapy may lead to worsening of navicular bursitis. Further work is needed to 
determine the mechanism of action of focused ESWT for both pain control and effect on tissues. 
In addition, validation of kinematic gait analysis for use in cases of bilateral forelimb lameness 
would increase the utility of this assessment tool, both clinically and in research settings.  
 
5.2 Introduction 
 Caudal heel pain is a commonly diagnosed cause of forelimb lameness in the horse 
(Sampson et al., 2009; Turner, 1989). With the advent of magnetic resonance imaging (MRI), 
accurate identification of abnormalities of structures in the caudal heel region has improved 
(Dyson et al., 2012, 2011a; Murray et al., 2006b; Parkes et al., 2015). The structures of the 
podotrochlear apparatus (PTA) include: the navicular bone, the collateral sesamoidean ligaments 
(CSL), the distal sesamoidean impar ligament (DSIL), the navicular bursa, and the distal portion 
of the deep digital flexor tendon (DDFT) (Busoni and Denoix, 2001; Dyson, 2011b). It is 
recognized that one or any combination of these structures can be affected in cases of caudal heel 
pain, although primary injury of the DDFT in the foot is now considered to be a separate clinical 
syndrome that may have similar clinical signs (Dyson et al., 2012; Lutter et al., 2015; Parkes et 
al., 2015). Abnormalities in the foot of horses affected with caudal heel pain often involve the 
flexor surface of the navicular bone in combination with the dorsal aspect of the DDFT (Blunden
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et al., 2006a; Wright et al., 1998). Other notable abnormalities include: navicular bone edema, 
desmitis of the CSL and/or DSIL, navicular bursitis, and distal border fragmentation of the 
navicular bone (Biggi and Dyson, 2012; Dyson et al., 2012; Murray et al., 2006b; Sampson et al., 
2009). The etiology of caudal heel pain has not been proven, but the degenerative disease is 
similar to osteoarthritis in other anatomical locations (Dyson et al., 2011a; Gabriel et al., 1998; 
Wright et al., 1998). A failure of biomechanics followed by chronic mechanical overload is 
supported by current research (Rijkenhuizen, 2006; Wilson et al., 2001; Wright et al., 1998). 
 Multiple treatment or management options have been used in cases of caudal heel pain 
with varying degrees of success. Success is often defined as a return to work or resolution of 
lameness for a period of time (Bell et al., 2009; Denoix et al., 2003; Gutierrez-Nibeyro et al., 
2010; Schoonover et al., 2005). Modulation of the disease process in an attempt to slow 
progression or induce healing is difficult when etiology is not fully understood. The focus of 
management in clinical cases is on control of symptoms clinical signs versus disease 
modification, and previous research has not investigated effect of treatment on MRI-diagnosed 
abnormalities. The mainstay of management is corrective trimming and shoeing techniques 
(Barrett et al., 2017; Schoonover et al., 2005). Other treatments include: intra-synovial 
medication with anti-inflammatories, systemic hemo-rheologics, systemic bisphosphonates, and 
various surgical methods (Baxter et al., 2011; Dabareiner and Carter, 2003). Medication of the 
navicular bursa with corticosteroids has been shown to reduce or resolve lameness for 2-16 
months (Bell et al., 2009; Dabareiner et al., 2003; Marsh et al., 2012; Verschooten et al., 1990). 
Bisphosphonate drugs such as tiludronate or clodronate reduce lameness associated with caudal 
heel pain, but do not alter disease progression on the basis of radiographic examination (Denoix 
et al., 2003; Frevel et al., 2014). Focused extracorporeal shock wave therapy (ESWT) has been 
used to alleviate lameness associated with caudal heel pain for a variable period of time 
(Dahlberg et al., 2006; McClure et al., 2004). 
 Focused ESWT is a pressure wave that can penetrate the tissues and cause cavitation. 
Initially developed for lithotripsy in human medicine, this therapy is now used in human and 
veterinary sports medicine as a general modality to decrease pain and improve healing for 
multiple musculoskeletal injuries, including tendonitis, desmitis, and osteoarthritis (Chung and 
Wiley, 2002; McClure and Dorfmüller, 2003). Purported mechanisms of action include: 
modulation of nerve conduction, increased blood flow through angiogenesis and 
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neovascularization, alteration of inflammation through induction and/or reduction of nitric oxide 
and growth factors, and induction of osteogenesis and bone remodeling (Caminoto et al., 2005; 
Cárcamo et al., 2012; Gotte et al., 2002; Kersh et al., 2006; Maier et al., 2003; Romeo et al., 
2013; Wang et al., 2009; F. S. Wang et al., 2002; Zhao et al., 2012). Doses of ESWT are typically 
reported using energy flux density (EFD), which is the amount of energy administered in 
millijoules (mJ) to one square millimetre (mm2) (McClure and Dorfmüller, 2003). Both focused 
and radial ESWT have previously been examined as a therapy for caudal heel pain with mixed 
results. Some studies have demonstrated that focused ESWT decreases pain and lameness 
associated with caudal heel pain (Bär et al., 2001; Blum, 2004; Dahlberg et al., 2006; McClure et 
al., 2004), although the duration of lameness improvement varied and no radiographic change 
over time was observed. Others have shown that radial ESWT affects neither lameness nor 
radiographs and scintigraphic results (Brown et al., 2005; Byron et al., 2009). Treatment 
protocols varied in these studies, and control groups were not used.  The effect of ESWT on 
lesions in the foot as diagnosed by MRI in horses has not been investigated. Additionally, the 
effects of ESWT on lameness caused by naturally occurring caudal heel pain in comparison to a 
control group have not been shown. 
 The null hypothesis of this study was that treatment with focused ESWT would not 
change subjective lameness scores, kinematic gait analysis parameters, or lesions identified on 
MRI associated with caudal heel pain in horses, when compared to controls. The objectives of 
this study were to determine the analgesic efficacy of focused ESWT on horses with naturally 
occurring caudal heel pain through subjective lameness assessment and kinematic gait analysis; 
and to determine the effect of this therapy on the appearance of lesions associated with caudal 
heel pain as diagnosed by MRI.  
 
5.3 Materials and Methods 
 
5.3.1 Animals 
 Client-owned horses (n=30) referred with a known or tentative diagnosis of caudal heel 
pain were recruited for this study. Recruitment occurred between June 2015 and August 2017. 
Study inclusion was based on a complete lameness examination performed by the authors (AVM, 
KAR) prior to enrolment, including a movement exam, diagnostic anesthesia, and radiography. 
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Inclusion criteria were: 1) lameness of >3 weeks duration, 2) unilateral or bilateral forelimb 
lameness notable at a trot in hand, 3) subjective improvement in lameness by more than 80% 
following a palmar digital nerve block of the affected limb(s), and 4) magnetic resonance 
imaging findings consistent with caudal heel pain as the primary cause of lameness. Exclusion 
criteria included 1) forelimb lameness not localized to the palmar heel region, 2) any bursal or 
articular injections to the palmar heel region within the prior 6 months, 3) any treatment with 
shock wave therapy or bisphosphonates in the prior 6 months, or 4) radiographic evidence of 
laminitis of the fore feet or osteoarthritis of the distal interphalangeal joint. Radiographic 
evidence of navicular region pathology was not required for study inclusion. 
 Horses were housed on their respective farms in pasture or paddock turnout based on owner 
preference. Housing and exercise of the horses was not restricted during the study period unless 
chosen by the owner. General recommendations for trimming of the front feet to increase heel 
mass and improve break over were given on an individual basis for each horse. The owner's 
regular farrier maintained foot care during the study period. Horses could not wear shoes for the 
duration of the trial. The use of analgesic and anti-inflammatory medications and supplements for 
the management of lameness was restricted for the study duration. 
 
This protocol was approved by the University Animal Care Committee at the University of 
Saskatchewan, and owners provided written consent for the use of their horse. 
 
5.3.2 Design 
 Horses were randomly assigned to one of two groups: control (n = 15) or treatment (n = 
15). Forelimbs were included only if all inclusion criteria were met. Data were collected at 5 time 
points within the study period (Table 5.1). Baseline for subjective lameness evaluation was 
established as day -16 (median, interquartile range (IQR): -28 to -13 days) to establish true 
lameness of each limb following diagnostic anesthesia at the inclusion examination. Baseline for 
kinematic gait analysis was on day 0, immediately prior to the first treatment. Baseline for MRI 
was on day -16. The times of the inclusion and final exams are stated as a median with the 
interquartile range to account for scheduling variability.  
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Table 5.1 Data collection time points for the study. 
 
Time Point Type of Data Collection or Monitoring 
Day -16 (median, IQR: 
-28 to -13 days) 
Complete Subjective Lameness Evaluation (inclusion exam) 
MRI 
Day 0 Kinematic Gait Analysis 
Subjective Lameness Evaluation (no diagnostic anesthesia performed) 
Day 14 Kinematic Gait Analysis 
Subjective Lameness Evaluation (no diagnostic anesthesia performed) 
Day 28 Kinematic Gait Analysis 
Subjective Lameness Evaluation (no diagnostic anesthesia performed) 
Day 128 (median, 
IQR: 123-138 days) 
Kinematic Gait Analysis 
Complete Subjective Lameness Evaluation (diagnostic anesthesia included) 
MRI 
MRI, magnetic resonance imaging 
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5.3.3 ESWT 
 The protocol used in this study was based on a combination of prior research (Bär et al., 
2001; Blum, 2004; Dahlberg et al., 2006; McClure et al., 2004a), manufacturer directionsa and 
anecdotal experience. Horses enrolled in the treatment group were administered ESWT to all 
included limbs three times at two-week intervals on days 0, 14, and 28. ESWT was performed 
with the horse standing, sedated by intravenous (IV) administration of xylazineb (0.2-0.3 mg/kg) 
or detomidinec (4-6 µg/kg) combined with butorphanold (4-6 µg/kg). The heel bulb region of each 
included forelimb was cleansed with chlorhexidine soape and isopropyl alcoholf prior to 
treatment, and coupling gelg was generously applied. An electrohydraulic shock wave generatorh 
was used. Shock waves (1,500 shocks) with an EFD of 0.28 mJ/mm2 at a frequency of 360 Hertz 
were applied to the heel bulb region with the limb weight bearing by authors (LER, KAR, STM) 
blinded to the lameness status of the horse. A trode with a penetration depth of 35 millimetres 
(mm) was used (35-mm trodei). The shock wave trode was moved continuously throughout the 
treatment and was directed at an angle towards the PTA (Figure 5.1). Horses in the control group 
were administered xylazine (0.2-0.3 mg/kg) or detomidine (4-6 µg/kg) combined with 
butorphanol (4-6 µg/kg) IV and had the heel region of the included forelimbs cleansed as if going 
to receive treatment, but ESWT was not applied on days 0, 14, and 28.  
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Figure 5.1 Angle of ESWT trode application to the heel region of the fore foot. 
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5.3.4 Subjective lameness evaluation 
 Horses were completely evaluated for lameness during the inclusion exam (median: day -
16; IQR: -28 to -13 days) and at day 128 (median; IQR: 123 to 138 days), including hoof tester 
exam, flexion tests and diagnostic anesthesia. A brief subjective lameness assessment consisting 
only of a movement exam was also performed at days 0, 14 and 28 prior to the administration of 
any sedation. At these time points, horses were observed at a walk and trot in a straight line and 
on circles in both directions. Lameness was graded for each limb on a scale from 0 to 5, with 0 
representing a normal gait and 5 representing non-weight bearing (severe) lameness using the 
scale recommended by the American Association of Equine Practitioners (AAEP) (Swanson, 
1984), as outlined in section 2.3.2.1. On days -16 and 128, the lamest limb was assigned a 
lameness grade prior to diagnostic anesthesia, and the less lame limb, if applicable, was assigned 
a lameness grade after the lamest limb was blocked. Subjective lameness grades for each limb 
from days -16 and 128 were combined to create a total lameness score representing total number 
of lameness units (0-10/10) per horse. Lameness evaluations were performed by the same 
veterinarian (AVM) who was blinded to group assignment.  
 
5.3.5 Kinematic gait analysis 
 Kinematic gait analysis was performed using a commercially available inertial sensor 
system (Lameness Locator®j) with three inertial sensors applied to the horse; one each on dorsal 
midline at the poll and tuber sacrale and one on the dorsal aspect of the right front pastern, as 
outlined by the user manualk. Variables obtained to reflect head movement asymmetry and 
therefore forelimb lameness measurements included: the mean difference in minimum and 
maximum head height (Hmin and Hmax, respectively) between right and left halves of the trot 
stride, standard deviation of Hmin and Hmax, and the vector sum (VS) of Hmin and Hmax in a 
straight line and on the circle in both directions, as previously described (Keegan et al., 2012). 
The VS is calculated from the Hmin and Hmax, and represents the overall measurement of head 
movement asymmetry in the vertical plane. Data were collected by the accompanying softwarel 
as described elsewhere (Keegan et al., 2013, 2011). Values for each trial were taken from a data 
output sheet generated by the software. 
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5.3.6 Magnetic resonance imaging 
 Magnetic resonance imaging was performed at days -16 and 128 for all horses using a 0.27-
Tesla standing equine MRI unitm and a specific equine foot radiofrequency coiln. Horses were 
sedated with acepromazineo (0.06 mg/kg administered intramuscularly), detomidine (4-6 µg/kg 
IV), butorphanol (4-6 µg/kg IV) and maintained under light standing sedation using detomidine 
(1-2 µg/kg) or xylazine (0.1-0.15 mg/kg) via IV bolus as needed. Images were obtained of each 
front foot in a standing position using the following pulse sequences: T1- and T2*- weighted 3-
dimensional (3D) gradient echo (GE), T2-weighted fast spin echo (FSE), proton density (PD) 
weighted FSE, and short tau inversion recovery (STIR) FSE with number of slices ranging from 
4-26. T1-weighted 3D gradient echo and STIR FSE images were obtained in dorsal, sagittal and 
transverse planes. T2-weighted FSE images were obtained in dorsal and transverse planes. T2*-
weighted 3D GE images were obtained in the sagittal plane. PD-weighted FSE images were 
obtained in a transverse plane. A T1-weighted 3D isotropic pulse sequence comprised of 112 
slices in the dorsal plane was added to the imaging protocol in January 2017; all MRI 
examinations completed before this date did not include this pulse sequence. Images were 
centered at the navicular bone. MRI images were interpreted by a single board-certified 
radiologist (NMW). Abnormalities were reported as mild, moderate or severe for each structure. 
Following interpretation, reported signal abnormalities were translated into grades by the author 
(AVM) with radiologist assistance (NMW) on a scale from 0-3, as per the grading system used 
by Murray et al. (2006b) and Biggi and Dyson (2011) (0: normal; 1: mild abnormalities; 2: 
moderate abnormalities; 3: severe abnormalities). An overall grade for the navicular bone was 
determined based on the sum of grades for each aspect of the bone, as per the grading system 
used by Biggi and Dyson (2011). An overall grade for the DDFT was determined based on the 
grading system published by Lutter et al. (2015). The radiologist was blinded to group 
assignment at all times and to degree of lameness at day 128. The author performing the grading 
was blinded to horse identity and group assignment.  
 
5.3.7 Statistical analysis 
 Descriptive statistical analysis was performed for all data, and data were analyzed for 
both individual horse and individual leg. Kinematic gait analysis data was checked for normality 
of distribution (Shapiro-Wilks, P>0.05) prior to using non-parametric statistical tests. The Fisher 
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exact and Wilcoxon rank sum tests were used to assess the difference in change in subjective 
lameness grade by leg (AAEP lameness scale, 0-5) and by horse (total lameness score, 0-10) 
between groups, between demographic subtypes, between each time point and over the entire 
study period. The Fisher exact and Kruskal-Wallis tests were used to compare the change in MRI 
grades between groups. Groups were evaluated for improvement versus worsening for both 
subjective lameness scores and MRI scores. Kinematic gait analysis data were transformed into 
the absolute values to represent the asymmetry of the horse regardless of the lame leg, and a leg 
variable was included. Groups were compared using a Wilcoxon rank sum test for all kinematic 
gait analysis variables. Analysis of all variables was repeated with all bilaterally lame horses 
removed, and then all unilaterally lame horses removed. A 2-way analysis of variance was used 
to test for associations between MRI grades and change in kinematic gait variables, despite lack 
of normality. Values of P<0.05 were considered significant. An initial power calculation 
indicated that a study population of 32 horses (16 per group) would be appropriate to determine if 
a difference of one lameness grade existed. A post-hoc power calculation was performed to 
determine if the change in horse number for the lameness data affected the statistical power when 
only unilateral horses were considered. Statistical softwarep was used to analyze the data. 
 
5.4 Results 
 Eighty-three horses were evaluated for inclusion, and 30 horses were enrolled in the study 
with 4 left forelimbs only, 7 right forelimbs only and 19 bilateral forelimbs for a total of 49 
limbs. The mean age was 11 years old (range: 6-18 years). Demographic and historical data was 
tabulated and was not significantly different between groups (see Table 5.2). Twenty-four horses 
completed the study within the designated time period; 5 had delays of study completion due to 
owner related factors and 1 horse developed an unrelated non-degenerative lameness that delayed 
study completion. Basic supportive treatment was provided for this horse until the complication 
resolved prior to completing the study period. The median day for inclusion exam procedures 
was day -16 (IQR: -28 to -13 days); for the control group this was day -16 (IQR: -23 to -13 days) 
and for the treatment group this was day -14 (IQR: -31 to -9 days). The median day for final 
exam procedures (from day 0 to final MRI) was day 128 (IQR: 123 to 138 days); for the control 
group this was day 125 (IQR: 118 to 133 days) and for the treatment group this was day 133 
 77 
(IQR: 126 to 141 days). Groups were not significantly different in time frame required to 
complete study procedures (p>0.05).  
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Table 5.2 Demographic information for the 30 horses enrolled in the study. No significant 
differences were noted between groups. 
 
  Demographic Characteristics 
  Sex Breed Lameness 
Duration 
Forelimb 
Lameness 
Group  Mare Gelding QH Paint Other <1 Yr >1 Yr Unilat Bilat 
Treatment # 8 7 11 4 0 6 9 4 11 
 % 53 47 73 27 0 40 60 27 73 
Control # 3 12 10 4 1 3 12 7 8 
 % 20 80 67 27 6 20 80 47 53 
Total # 11 19 21 8 1 9 21 11 19 
 % 37 63 70 27 3 30 70 37 63 
QH, Quarter Horse; Unilat, unilateral; Bilat, bilateral; Yr, year 
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5.4.1 Subjective lameness evaluation 
 The lameness grade per limb (n=49) at day -16 and day 128 are shown in Figures 5.2 and 
5.3. There were no significant differences between groups at either time point. There was a mean 
decrease in 1 lameness grade per leg from day -16 to day 128 in both groups (range: decrease by 
3 grades to increase by 1 grade); groups were not significantly different (p>0.05). 
 The median total lameness score per horse at baseline (day -16) was 5/10 units (IQR: 3-
6/10 units); groups were not significantly different. The median total lameness score at day 128 
per horse was 3/10 units (IQR: 2-4/10 units); median for the control group was 3/10 units (IQR: 
2-4/10 units) and the treatment group was 2/10 units (IQR: 1-5/10 units). The median change in 
total horse lameness score was -1 units (IQR: -2 to 0 units) for the control group and -2 units 
(IQR: -3 to -1 units) for the treatment group (p=0.15). If only unilaterally lame horses (n = 11) 
were considered, the control group (n=7) experienced no change in total lameness score (a 
median change of 0 lameness units; IQR: -1 to 1 units) and the treatment group (n=4) 
experienced a significantly different median decrease of 1 lameness units (IQR: -2 to -1 units), as 
shown in Figure 5.4 (Wilcoxon Rank Sum, p=0.049). There was no significant effect of MRI 
grade on subjective lameness assessment outcomes (p>0.05).  
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Figure 5.2 Baseline grade of lameness, by leg, separated by group (percent of legs per grade). 
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Figure 5.3 Final grade of lameness, by leg, separated by group (percent of legs per grade). 
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Figure 5.4 Change in total lameness score (0-10/10) per horse between day -16 and day 128 
separated by group and by bilateral or unilateral lameness. Median values that are significantly 
different (p<0.05) are indicated by different letters.  
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5.4.2 Kinematic gait analysis 
 Absolute values of all kinematic gait analysis data are reported here, as described in 
section 5.3.7. Kinematic gait analysis is not validated for use with bilaterally lame horses due to 
muting of measurable asymmetry. Muting of asymmetry was present in this population of horses 
that had bilateral forelimb lameness. The median straight line vector sum for unilaterally included 
horses at day 0 was 22.3 mm (IQR: 10.9 to 24.4 mm); the median straight line vector sum for 
bilaterally included horses at day 0 was 17.3 mm (IQR: 10.8 to 21.6 mm); no significant 
difference was present (p>0.05). Despite the lack of statistical significance, decreased measurable 
asymmetry in bilaterally lame horses represents an important biological consideration with 
clinical relevance to the analyzed data. With this in mind, only data for horses enrolled with a 
unilateral forelimb lameness is presented. There were no significant differences in outcomes 
when all horses were included in the analysis.  
 The median straight line absolute value vector sum at baseline of 22.3 mm in unilaterally 
lame horses is over the established threshold for lamenessk of 8.5 mm and is consistent with the 
subjective lameness evaluation results. The median right circle absolute value vector sum at 
baseline was 22.6 mm (IQR: 11.8 to 31.0 mm). The median left circle absolute value vector sum 
at baseline was 16.6 mm (IQR: 8.5 to 33.4 mm). Groups were not significantly different at 
baseline for all variables. The distribution of the absolute values of vector sum, Hmin and Hmax 
over time for the straight line, left circle and right circle are shown in Appendix B. The change in 
absolute value of vector sum, Hmin and Hmax for each trial type (straight line, left circle, right 
circle) between day 0 and day 128 were calculated and compared between groups; the 
distribution of change between groups is shown in Figures 5.5-7. A decrease in absolute value 
represents a decrease in asymmetry and therefore improvement in lameness as measured by the 
inertial sensor system. No significant differences were noted between groups for change in 
variables, but there was a trend for the treatment group to have a larger degree of decrease in 
some kinematic parameters than the control group, as shown in Figures 5.5-7. A decrease in 
kinematic parameters in unilaterally lame horses indicates a decrease in asymmetry and therefore 
a decrease in lamenessk.  
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Figure 5.5 Change in kinematic gait analysis variables (VS, Hmin, Hmax) from day 0 to day 128 
in a straight line (unilateral horses only), separated by group. 
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Figure 5.6 Change in kinematic gait analysis variables (VS, Hmin, Hmax) from day 0 to day 128 
in a left circle (unilateral horses only), separated by group. 
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Figure 5.7 Change in kinematic gait analysis variables (VS, Hmin, Hmax) from day 0 to day 128 
in a right circle (unilateral horses only), separated by group. 
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5.4.3 MRI 
 Lesion grades on MRI at day -16 (by limb, n=49) are shown in Table 5.3. The control 
group had 23 limbs and the treatment group had 26 limbs included in the study. Groups were not 
significantly different at baseline. Adhesions involving the DDFT were identified in 43% of 
limbs (21 limbs; 8 limbs (35%) in the control group and 13 limbs (50%) in the treatment group). 
Lesion grades on MRI at day 128 (by leg, n=49) are shown in Table 5.4. At day 128, an 
additional 4 limbs had developed identifiable adhesions involving the DDFT, 3 in the control 
group and 1 in the treatment group. This change was not statistically significant (p>0.05). Degree 
of change (worse, no change, better) in lesion grades from day -16 to day 128 was compared 
between groups and is shown in Table 5.5. More limbs in the treatment group had a worsening of 
navicular bursitis, and more limbs in the control group had an improvement in navicular bursitis 
(p=0.027). A similar but insignificant trend was noted with navicular bone fluid (p=0.12) and 
navicular bone overall grade (p=0.18). Limbs in the treatment group with an increase or 
worsening of navicular bursa grade (n=7) showed an overall improvement in lameness grade; 
only a single limb worsened by 1 lameness grade; although this was not statistically significant 
(p>0.05). Degree of change in MRI grades was evaluated with bilaterally lame horses removed; 
no significant differences between groups were noted. Degree of change in MRI grades was 
evaluated with unilaterally lame horses removed (bilaterally lame horses, n= 19, # of limbs = 38). 
Bilaterally lame horses enrolled in the control group (n=8) had significantly more improvement 
in navicular bursitis (p=0.008) and a trend for more improvement in navicular bone fluid 
(p=0.072) than bilaterally lame horses enrolled in the treatment group (n=11).  
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Table 5.3 Number and proportion (%) of limbs graded 0 (normal) to 3 (severe abnormality) for 
lesions or signal abnormalities in podotrochlear structures on MRI at day -16 in horses from the 
treatment (15 horses, 26 limbs) and control (15 horses, 23 limbs) groups. 
 
 
Structure Grade 0 Grade 1 Grade 2 Grade 3 
 Control 
# (%) 
Treatment 
# (%) 
Control 
# (%) 
Treatment 
# (%) 
Control 
# (%) 
Treatment 
# (%) 
Control 
# (%) 
Treatment 
# (%) 
Navicular Bone         
Flexor Surface 14 (61) 18 (69) 1 (4) 0 (0) 1 (4) 1 (4) 7 (31) 7 (27) 
Synovial 
Invaginations 
10 (44) 10 (38) 6 (26) 9 (35) 7 (30) 6 (23) 0 (0) 1 (4) 
Distal Border 11 (48) 8 (31) 7 (30) 11 (42) 5 (22) 5 (19) 0 (0) 2 (8) 
Medulla (Fluid) 1 (4) 0 (0) 11 (48) 16 (62) 9 (39) 5 (19) 2 (9) 5 (19) 
Proximal Border 20 (87) 22 (85) 0 (0) 1 (4) 3 (13) 3 (12) 0 (0) 0 (0) 
Max Grade 0 (0) 0 (0) 8 (35) 12 (46) 8 (35) 6 (23) 7 (30) 8 (31) 
Overall Grade 0 (0) 0 (0) 16 (70) 16 (61) 6 (26) 8 (31) 1 (4) 2 (8) 
DSIL 7 (30) 17 (65) 13 (57) 8 (31) 3 (13) 1 (4) 0 (0) 0 (0) 
P3 (Fluid) 13 (57) 21 (81) 7 (30) 4 (15) 3 (13) 1 (4) 0 (0) 0 (0) 
CSL 5 (22) 6 (23) 8 (35) 16 (62) 10 (43) 4 (15) 0 (0) 0 (0) 
DDFT Overall 
Grade 
2 (9) 1 (4) 7 (30) 14 (54) 14 (61) 11 (42) 0 (0) 0 (0) 
Navicular Bursa 
(Bursitis) 
2 (9) 5 (19) 9 (39) 11 (42) 9 (39) 10 (38) 3 (13) 0 (0) 
DSIL, distal sesamoidean impar ligament; P3, third phalanx; CSL, collateral sesamoidean 
ligaments; DDFT, deep digital flexor tendon 
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Table 5.4 Number and proportion (%) of limbs graded 0 (normal) to 3 (severe abnormality) for 
lesions or signal abnormalities in podotrochlear structures on MRI at day 128 in horses from the 
treatment (15 horses, 26 limbs) and control (15 horses, 23 limbs) groups. 
 
 
Structure Grade 0 Grade 1 Grade 2 Grade 3 
 Control 
# (%) 
Treatment 
# (%) 
Control 
# (%) 
Treatment 
# (%) 
Control 
# (%) 
Treatment 
# (%) 
Control 
# (%) 
Treatment 
# (%) 
Navicular Bone         
Flexor Surface 12 (52) 18 (69) 1 (4) 1 (4) 1 (4) 0 (0) 9 (39) 7 (27) 
Synovial 
Invaginations 
10 (44) 9 (35) 6 (26) 9 (35) 7 (30) 7 (27) 0 (0) 1 (4) 
Distal Border 9 (39) 8 (31) 7 (30) 7 (27) 6 (26) 10 (38) 1 (4) 1 (4) 
Medulla (Fluid) 2 (9) 0 (0) 14 (61) 14 (54) 6 (26) 7 (27) 1 (4) 5 (19) 
Proximal 
Border 
20 (87) 22 (85) 0 (0) 0 (0) 3 (13) 4 (15) 0 (0) 0 (0) 
Max Grade 1 (4) 0 (0) 8 (35) 10 (38) 5 (22) 8 (31) 9 (39) 8 (31) 
Overall Grade 1 (4) 0 (0) 13 (57) 16 (62) 8 (35) 9 (35) 1 (4) 1 (4) 
DSIL 12 (52) 14 (54) 8 (35) 12 (46) 2 (9) 0 (0) 1 (4) 0 (0) 
P3 (Fluid) 16 (70) 22 (85) 6 (26) 4 (15) 1 (4) 0 (0) 0 (0) 0 (0) 
CSL 2 (9) 4 (15) 8 (35) 17 (65) 13 (57) 5 (9) 0 (0) 0 (0) 
DDFT Overall 
Grade 
2 (9) 0 (0) 7 (30) 15 (58) 13 (57) 11 (42) 1 (4) 0 (0) 
Navicular Bursa 
(Bursitis) 
4 (17) 1 (4) 11 (48) 13 (50) 6 (26) 12 (46) 2 (9) 0 (0) 
DSIL, distal sesamoidean impar ligament; P3, third phalanx; CSL, collateral sesamoidean 
ligaments; DDFT, deep digital flexor tendon 
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Table 5.5 Number and proportion (%) of limbs with a change in lesion grade on MRI between 
day -16 and day 128 by identified lesions and signal abnormalities in podotrochlear structures in 
horses from the treatment (15 horses, 26 limbs) and control (15 horses, 23 limbs) groups; P value 
indicates comparison between groups. 
 
 
Structure Worse No Change Better P value 
 Control 
# (%) 
Treatment 
# (%) 
Control 
# (%) 
Treatment 
# (%) 
Control 
# (%) 
Treatment 
# (%) 
 
Navicular Bone        
Flexor Surface 3 (13) 1 (4) 20 (87) 24 (92) 0 (0) 1 (4) 0.33 
Synovial 
Invaginations 
0 (0) 1 (4) 23 (100) 25 (96) 0 (0) 0 (0) 0.53 
Distal Border 5 (22) 4 (15) 18 (78) 21 (81) 0 (0) 1 (4) 0.85 
Medulla (Fluid) 2 (9) 4 (15) 14 (61) 20 (77) 7 (30) 2 (8) 0.12 
Proximal Border 0 (0) 1 (4) 23 (100) 25 (96) 0 (0) 0 (0) 0.53 
Max Grade 2 (9) 3 (12) 19 (83) 22 (85) 2 (9) 1 (4) 0.86 
Overall Grade 8 (35) 6 (23) 8 (35) 16 (62) 7 (30) 4 (15) 0.18 
DSIL 3 (13) 4 (15) 14 (61) 20 (77) 6 (26) 2 (8) 0.27 
P3 (Fluid) 1 (4) 2 (8) 17 (74) 20 (77) 5 (22) 4 (15) 0.89 
CSL 4 (17) 2 (8) 19 (83) 24 (92) 0 (0) 0 (0) 0.28 
DDFT Overall Grade 3 (13) 1 (4) 18 (78) 24 (92) 2 (9) 1 (4) 0.4 
Navicular Bursa 
(Bursitis) 
1 (4) 7 (27) 15 (65) 17 (65) 7 (30) 2 (8) 0.027 
DSIL, distal sesamoidean impar ligament; P3, third phalanx; CSL, collateral sesamoidean 
ligaments; DDFT, deep digital flexor tendon 
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5.4.4 Adverse effects 
 Minimal adverse effects of ESWT were noted in the treatment group. One owner reported 
moderately increased lameness for 1-2 days immediately following each treatment that resolved 
without additional care. 
 
5.5 Discussion 
 The results of this research suggest that focused ESWT provides incomplete pain relief in 
horses with naturally occurring unilateral caudal heel pain for at least 128 days when compared to 
a control group. This was supported by statistically significant differences in subjective lameness 
evaluation between groups, and non-statistically significant trends in the kinematic gait 
evaluation data. Previous research indicated that focused ESWT alleviated lameness associated 
with caudal heel pain for a variable period of time of 2 days to 12 months following treatment 
(Bär et al., 2001; Blum, 2004; Dahlberg et al., 2006; McClure et al., 2004), however all previous 
work on this topic was performed in an uncontrolled manner. A lack of a control group in these 
studies introduces significant bias and decreases the strength of the results. The results presented 
in the current study show a mild reduction in subjective lameness grade over a period of 128 days 
(on average) regardless of group assignment, so it is possible that the reduction of lameness 
reported in other studies is due to the fluctuating nature of lameness associated with caudal heel 
pain (Parkes et al., 2015). The sample size (n=30) in the current study was close to the estimate 
provided by the power calculation and should have allowed for an obvious difference to be seen 
between groups, should one exist. However, only unilaterally lame horses showed statistically 
significant improvement over the control group. When only unilaterally lame horses were 
included in the analysis, the sample size was dramatically reduced to 11 horses.  
 The current study used 1,500 shocks at an EFD of 0.28 mJ/mm2. It is possible that this 
ESWT dosing protocol was not the required dose to induce positive change in the injured tissues. 
It has been shown that there is a dose-dependent response in tissues following treatment with 
ESWT, with lower EFD stimulating positive biochemical responses and higher EFD (more than 
0.5 - 0.6 mJ/mm2) causing detrimental tissue disruption in laboratory animals (Maier et al., 2002; 
Orhan et al., 2004; Rompe et al., 1998). Multiple studies of ESWT use in horses, including for 
caudal heel pain, have evaluated a dose of approximately 0.15 mJ/mm2 (Blum, 2004; Caminoto 
et al., 2005; Frisbie et al., 2009; Kawcak et al., 2011), although another group saw a reduction in 
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lameness using a dose of 0.89 mJ/mm2 in horses with caudal heel pain (McClure et al., 2004). 
However, it has not been shown in horses what a reasonable or productive EFD is, and the 
protocol used in this study was based on a combination of these prior references, 
recommendations provided by the manufacturera and previous personal experience with the 
therapy by multiple authors (KAT, AVM). The use of a 35-mm hand-piece was deemed 
appropriate based on the approximate distance between the skin of the heel bulbs and the 
navicular bone (Blum, 2004). Also, Blum (2004) determined that the outcome was improved if 
ESWT was applied between the heel bulbs with the horse weight bearing instead of through the 
palmar aspect of the frog. This method was used in the current study, with less appreciable 
improvement in lameness when compared to a control group. 
 The inability of kinematic gait analysis to accurately quantify bilateral forelimb lameness 
represents a significant and unforeseen limitation of this research. Kinematic gait analysis with 
inertial sensors relies on asymmetry between halves of the trot stride to detect the presence and 
amplitude of a lameness (Keegan et al., 2013). In cases of forelimb lameness, the sensors detect 
the abnormal acceleration of the head as the horse attempts to offload the lame limb at the trot. 
Horses with bilateral forelimb lameness may mute this head movement as they attempt to offload 
both lame limbs (Keegan et al., 2012), rendering the measured asymmetry between stride halves 
a smaller value when lameness is not isolated to a single limb, as demonstrated in the current 
study. This biologically important effect may reduce the validity and repeatability of the data, 
limiting comparisons over time for a given animal. Given this lack of validation, the kinematic 
gait analysis data for the bilateral horses could not be included in the final analysis, reducing the 
power of this study. The kinematic gait analysis results with the bilateral horses included versus 
excluded were not statistically significantly different, although it was determined that bilaterally 
lame horses do not experience the same improvement in subjectively evaluated lameness as 
unilaterally lame horses do following treatment with ESWT. Prior research has used both 
unilaterally and bilaterally lame horses to note an effect of ESWT in cases of caudal heel pain via 
subjective gait assessment (Bär et al., 2001; Blum, 2004; McClure et al., 2004a). However, even 
subjective lameness grading methods have difficulty in accurately identifying the severity of or 
improvement in bilateral forelimb lameness without eliminating one of the lame limbs through 
diagnostic anesthesia (Dyson, 2011a). Finally, the change in subjective lameness grade in both 
groups was only a decrease in one lameness grade, which could be a reflection of intra-observer 
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variability (Dyson, 2011a), or due to the known fluctuation in lameness that occurs in horses with 
caudal heel pain (Parkes et al., 2015).  
 Previous research showed no evidence of lesion change on radiographs or nuclear 
scintigraphy in horses with caudal heel pain following treatment with focused or radial ESWT 
(Bär et al., 2001; Byron et al., 2009). The current study used MRI to determine an effect of 
therapy on lesion appearance. The increase in inflammation within the navicular bursa in treated 
horses does not agree with the reported anti-inflammatory and potential disease-modifying effect 
of ESWT in other species (Chamberlain and Colborne, 2016; Mariotto et al., 2009), and was a 
surprising finding. The true mechanism by which focused ESWT stimulates healing and 
regeneration in musculoskeletal tissue in horses is incompletely determined. It has been shown in 
other species that the therapy stimulates a partial inflammatory response in osseous tissues 
through immediate increased substance P expression (Maier et al., 2003), yet stimulates an anti-
inflammatory response in connective tissues via increased nitric oxide expression (Gotte et al., 
2002; Wang et al., 2009, 2011b). However, another group determined that ESWT caused 
decreased nitric oxide expression, resulting in disease-modifying effects at the cartilage level 
(Zhao et al., 2012). In laboratory animals and humans, the therapy may promote bone healing in 
non-union fractures through increasing transforming growth factor-beta-1 (TGF-b1)  (Wang et 
al., 2009), and may enhance angiogenesis and neovascularization through increasing vascular 
endothelial growth factor release (Wang et al., 2011a, 2008). Vascular endothelial growth factor 
and TGF-b1 is known to improve neovascularization of injured connective tissues in horses, 
which could result in more effective healing (Bosch et al., 2011; Dahlgren et al., 2005). Low dose 
ESWT failed to induce an increase in vascular endothelial growth factor, TGF-b1, and insulin 
like growth factor 1 in experimentally induced skin wounds in horses (Morgan et al., 2009). 
Contrarily, low dose ESWT applied to induced suspensory ligament desmitis in horses resulted in 
an increase in TGF-b1 (Caminoto et al., 2005). The specific role of these biomolecules in caudal 
heel pain in the horse is unknown, and the effects of potentially increased growth factors on 
lesion progression on MRI has not been determined. When focused ESWT was used to treat 
experimentally induced osteoarthritis in horses, an increase in serum biomarkers indicating bone 
remodeling was determined, but no histological effects were noted within the subchondral bone 
(Kawcak et al., 2011). In a similar osteoarthritis model, no disease modifying effects were found 
following treatment with focused ESWT, although there was a decrease in synovitis in treated 
 94 
joints due to a statistically insignificant decrease in synovial fluid protein concentration (Frisbie 
et al., 2009); this finding was not supported by our results.  
 Navicular bursitis is characterized by an increase in fluid volume and the presence of 
synovial proliferation (hyperplasia) on MRI (Bell et al., 2009; Murray et al., 2006b). The results 
reported in the current study suggest that inflammation within the navicular bursa increased 
despite a mild decrease in lameness in horses treated with focused ESWT. This result is 
unexpected, and contrary to widespread accepted understanding of caudal heel pain. 
Inflammation and distension of the navicular bursa created experimentally in normal horses 
causes lameness (Pleasant et al., 1997). It is thought that naturally occurring navicular bursitis 
contributes to lameness in cases of caudal heel pain (Blunden et al., 2006a; Dyson et al., 2005; 
Murray et al., 2006b) but it is difficult to discern which lesion in the foot causes the most pain in 
horses with multiple lesions, given the closely related structures in the distal limb and lack of 
specificity of intra-synovial diagnostic anesthetic techniques in the foot (Parkes et al., 2015; 
Schumacher et al., 2001b, 2003). Intra-synovial administration of local anesthetic into the 
navicular bursa improves lameness associated with caudal heel pain, including navicular bursitis 
and other lesions of the PTA (Bell et al., 2009; Dyson and Kidd, 2003; Parkes et al., 2015), but 
anesthesia of the navicular bursa may also desensitize the sole and the distal interphalangeal joint 
(Schumacher et al., 2001b, 2003). With this in mind, perhaps navicular bursitis does not 
contribute to lameness as much as previously thought, especially in cases of advanced caudal heel 
pain with multiple abnormalities present. It is also possible that treatment with focused ESWT 
resulted in a partial decrease in pain sensation, allowing potential overuse and exacerbation of 
bursitis. It has been shown that ESWT can decrease local skin sensation in a treated region in 
horses, but that analgesia of the entire treated nerve field is not produced (McClure et al., 2005). 
In addition, inflammation is noted in treated nerves in sheep (McClure et al., 2005), but there is 
no change in substance P concentrations or other neuropeptides to explain any analgesic effect 
(Abed et al., 2007). Treatment of equine peripheral nerves with radial ESWT resulted in 
decreased sensory nerve conduction velocity, but cutaneous analgesia was not evaluated (Bolt et 
al., 2004a). The presence of worsened navicular bursitis in the current study may indicate that 
treatment with focused ESWT caused an inflammatory reaction. The effects of ESWT in equine 
tissues beyond 105 days (McClure et al., 2004c) have not previously been determined, so it is 
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possible that the sequence of inflammatory and anti-inflammatory events varies between tissue 
types, and that analgesia may be unrelated to the effects of the therapy on cells and tissues.  
 There was an overwhelming lack of change in MRI lesion grades despite group 
assignment. While not statistically significant, the trend of increasing navicular bone medulla 
fluid signal grade in treated horses could be due to angiogenesis within the navicular bone 
medulla. Increased fluid signal within the navicular bone on fat suppressed sequences can 
indicate edema, contusion, angiogenesis, osteonecrosis or degeneration, fibrosis, or inflammatory 
infiltrate (Murray et al., 2006a; Werpy, 2012). The cause of navicular bone fluid can only be 
determined by histopathology, which was not performed in the current study. It is possible that 
the overall severity of lesions in this particular group of horses limited the possible effects of the 
therapy, or that the lack of change on MRI indicated that the lesions noted were static and 
permanent (Werpy, 2012). Permanent navicular bone fluid could indicate more substantial 
osseous injury and degeneration that may not respond to treatment with focused ESWT.  It is also 
possible that the timeline used to assess lesion change in this study was inappropriate to detect an 
effect of treatment. Prior research using ESWT has evaluated lesion change as early as 3 hours 
(Bosch et al., 2009) and as long as 105 days following treatment  (McClure et al., 2004c). The 
time point used in this study (128 days, approximately 4.25 months) reflects the 
recommendations for recheck imaging as reported by Werpy (2012). It is possible that results 
would have differed if MRI was performed on a different timeline, for example immediately after 
the third treatment. It has been recommended that osseous fluid should be rechecked in 2-4 
months, 6 if severe, and DDFT lesions should be rechecked in 5-7 months on average (Werpy, 
2012). All horses in this study had some degree of osseous fluid within the navicular bone and at 
least one soft tissue structure affected, rendering an appropriate recheck time period somewhere 
between 2-7 months. It is unknown why a greater difference was noted in MRI grade change 
between groups when only bilaterally lame horses were considered. 
 Caudal heel pain is a difficult disease to maintain as a constant measured lameness, given 
the intermittent worsening and improvement of clinical signs that is often noted and the variation 
in possible lesions (Parkes et al., 2015). This naturally occurring disease state represents a 
limitation of this study, because it is impossible to control for all of the factors that may 
contribute to lameness and disease progression. All horses had some degree of navicular bone 
abnormalities in conjunction with soft tissue injury that were localized with diagnostic 
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anesthesia, and differences were not statistically different between groups. Further work should 
focus on the appearance and progression of types of lesions associated with caudal heel pain on 
MRI, and response to available therapies. 
 This study attempted to mimic the circumstances encountered in clinical practice, but the 
use of client-owned animals was also a limitation of this study. It was specified that clients could 
choose turnout and exercise for their horse, although most horses were given a period of rest 
during the study period at owner discretion and all were maintained on large paddock or pasture 
turnout. Relying on client compliance with recommendations is paramount for horse outcomes in 
cases of musculoskeletal injury. 
 Results of the current study were unable to provide an explanation for the mild 
improvement in lameness that was observed in the unilaterally lame horses in the treatment 
group. It cannot be determined from the results of the current study if focused ESWT is truly 
disease-modifying in cases of caudal heel pain, or if there is simply a reduction in lameness due 
to disrupted nerve conduction. However, it appears that treatment with focused ESWT does not 
result in any significant lesion resolution or improvement based on MRI when evaluated at this 
interval, and may result in worsening of navicular bursitis and increased STIR intensity within 
the navicular bone.  
 In conclusion, this study indicated that treatment with focused ESWT caused a mild 
decrease in subjectively assessed lameness in unilaterally lame horses when compared to a 
control group, but not in all horses included in the study. Despite this, navicular bursitis worsened 
in the treatment group but improved in the control group. Kinematic gait analysis was not useful 
for objective assessment of lameness in bilaterally lame horses due to muting of measured 
asymmetry, and no significant differences were present between groups if only unilateral horses 
were evaluated. To address limitations of this study, further research should focus on validation 
of kinematic gait analysis in bilaterally lame horses, elucidation of the concentration of growth 
factors and other biomolecules present in cases of caudal heel pain, determination of the true 
mechanism of action of ESWT on equine tissues over time, and the use of ESWT as a possible 
concurrent treatment method for caudal heel pain in combination with other therapies.  
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5.6 Footnotes 
 
a. VersaTron® Treatment Protocols, Pulse Veterinary Technologies LLC, Alpharetta, GA, USA 
b. Xylazine hydrochloride, Rompun 100 mg/mL Injectable, Bayer, Mississauga, ON, Canada 
c. Detomidine hydrochloride, Dormosedan, Pfizer Animal Health, Kirkland, QC, Canada 
d. Butorphanol tartrate, Torbugesic, Zoetis, Kirkland, QC, Canada 
e. Chlorhexidine gluconate solution 4%, Stanhexidine, Omega Laboratories Ltd, Montreal, QC, 
Canada 
f. Isopropyl alcohol 70%, RW Packaging Ltd, Winnipeg, MB, Canada 
g. Aquasonic® Ultrasound Transmission Gel, Parker Laboratories Inc., Fairfield, NJ, USA 
h. VersaTron®, Pulse Veterinary Technologies LLC, Alpharetta, GA, USA 
i. 35 mm trode, VersaTron®, Pulse Veterinary Technologies LLC, Alpharetta, GA, USA 
j. Lameness Locator®, Equinosis LLC, Columbia, MO, USA 
k. The Equinosis Q with Lameness Locator® User Manual 2017, Equinosis LLC, Columbia, 
MO, USA 
l. The Equinosis Q 2027 v1.1, Equinosis LLC, Columbia, MO, USA 
m. 0.27-Tesla Standing Equine MRI, Hallmarq Veterinary Imaging Inc., Acton, MA, USA 
n. Equine hoof receiver coil, Hallmarq Veterinary Imaging Inc., Acton, MA, USA 
o. Acepromazine, Acevet 25 Injectable, Vetoquinol, Lavaltrie, QC, Canada 
p. Stata®, StataCorp LP, College Station, TX. 
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6.1 Introduction 
 Extracorporeal shock wave therapy (ESWT) was anecdotally thought to be a widely used 
treatment modality in equine practice, primarily for musculoskeletal injuries. The therapy has 
been shown to provide analgesia in some horses affected by caudal heel pain, but not all research 
in this regard has used proper controls or blinding (Bär et al., 2001; Blum, 2004; Dahlberg et al., 
2006; McClure et al., 2004a). While analgesia is one aspect of a desirable treatment for caudal 
heel pain, the effect of the therapy on disease progression is important to guide clinical decision 
making. Caudal heel pain of the forelimbs in horses is accurately diagnosed with MRI (Parkes et 
al., 2015; Sampson et al., 2009), making MRI a useful tool to evaluate treatment effect (Werpy, 
2012).  
 
6.2 General Results and Future Studies 
 The goal of this research was to characterize the use of ESWT among equine practitioners 
in North America, and to determine the effect of ESWT on both the degree of lameness and the 
appearance of lesions diagnosed by MRI in horses with naturally occurring caudal heel pain.  
 The first specific aim, to characterize the use of ESWT in regard to frequency of use, 
diseases treated, and clinical opinion of therapy efficacy was determined by surveying a 
population of equine practitioners (n=144) (Chapter 4). Data showed that 45.1% of respondents 
used ESWT frequently, 42.4% of respondents use the therapy infrequently, and only 12.5% never 
used the modality in their practice. Use of ESWT was positively associated with the amount of 
equine work in the respondent's veterinary practice. Most respondents (94.4%) used ESWT to 
treat ligament injuries. Other types of injuries frequently treated with ESWT included tendon 
injuries (76.8% of respondents), muscle pain (63.2% of respondents), and osteoarthritis (51.2%). 
Caudal heel pain was treated by 27.2% of respondents. ESWT was viewed by respondents as a 
highly effective treatment option for ligament injuries and muscle pain management, but an 
ineffective treatment option for osteoarthritis and navicular syndrome. Non-response bias likely 
had an effect on the results of the survey. A low number of respondents was a factor in this 
limitation. 
 The second specific aim of this thesis was to determine the analgesic efficacy of focused 
ESWT as a treatment for horses with caudal heel pain (Chapter 5). The third specific aim of this 
thesis was to determine the effect of focused ESWT on the appearance of lesions diagnosed by 
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MRI in horses with naturally occurring caudal heel pain (Chapter 5). Analgesic efficacy was 
evaluated by change in subjectively evaluated lameness and change in kinematic gait analysis 
parameters. Effect on lesions was evaluated by change in lesion appearance on repeat MRI. 
ESWT was applied to the heel region of the horses in the treatment group at a dose of 1,500 
shocks with an EFD of 0.28 mJ/mm2 for 3 treatments. Data showed that unilaterally lame horses 
had improvement in subjectively evaluated lameness following treatment with ESWT, compared 
to the control group. Kinematic gait analysis was not useful for evaluating bilaterally lame 
horses, which limited the power of this portion of the analysis. Horses in the control group had 
improvement in navicular bursitis, while horses in the treatment group worsened.  
 The use of a naturally occurring disease was a factor in the limitations of Chapter 5. 
Inherent variability in degree of lameness and natural progression of the disease was impossible 
to control for in the study design. This, combined with intra-observer variability, affects the 
usefulness of repeated subjective lameness evaluation over time. Kinematic gait analysis was 
used to provide objective data regarding lameness improvement, but the unforeseen muting of 
asymmetry in bilaterally lame horses lead to a significant reduction in sample size and therefore, 
statistical power of the experiment.  
 Future studies using a larger sample size of unilaterally lame horses need to be conducted 
prior to recommending ESWT as a treatment option for all horses affected with caudal heel pain. 
Additionally, it would be useful to validate kinematic gait analysis as an objective lameness 
measurement tool for bilaterally lame horses. Investigation into the biochemical and molecular 
effects of ESWT in the caudal heel region may elucidate the mechanism of action of this therapy. 
Further surveys of equine practitioners regarding ESWT use should focus on specific doses used 
for different injuries to determine if practitioners are seeing a dose-dependent effect of the 
therapy. If results are informative, perhaps ESWT use could be optimized for caudal heel pain. 
 
6.3 Conclusion 
 In conclusion, we have demonstrated that ESWT is used relatively commonly by equine 
practitioners, and that focused ESWT does not improve lesions associated with caudal heel pain 
when using an EFD of 0.28 mJ/mm2, but may provide analgesia for some horses. Further 
research is required to evaluate alternative dosing protocols for ESWT and to determine the 
mechanism of action of ESWT. 
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APPENDIX A 
 
The introductory letter for the survey and survey questions used for Chapter 4 are provided as 
supplementary information, shown in the format used in the survey engine. If the respondent 
indicated that they never used ESWT, questions 3 to 15 regarding clinical use of the therapy were 
automatically skipped by the survey engine. An asterisk (*) indicates that the survey engine 
required a response. 
 
Dear Colleague, 
 
Extracorporeal and/or radial shockwave therapy has gained popularity as a treatment option in equine 
practice for multiple conditions. Initially developed to dissolve kidney stones in people, this treatment 
modality may have the potential to be a useful non-invasive option for musculoskeletal problems in 
horses. 
 
The objective of this survey is to characterize the use of shockwave therapy among equine 
practitioners. All questions are multiple choice, rating scale or a brief answer box, although comments 
are welcome. This survey will take no more than 15 minutes of your time to complete. Please continue 
with the survey even if you do not use shockwave therapy. 
 
Your participation in completing this survey is appreciated, and will help to define the perceived 
clinical value of shockwave therapy in treating varied musculoskeletal issues in horses. This survey 
will, in part, satisfy the requirements for my Master of Science degree. The results of this study will be 
circulated to all participants later this year. Identifying information will remain confidential; however if 
you wish to remain anonymous, feel free to leave the personal information fields blank. 
 
If you have any questions, please contact Angela MacKay at the email address or phone number below. 
Thank you for volunteering your time for this survey. 
 
Angela MacKay, DVM 
Resident, Equine Field 
Service 
Western College of Veterinary 
Medicine University of 
Saskatchewan 
(306) 966-7178 
angela.mackay@usask.ca 
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* 1. How often do you use shockwave therapy on horses in your practice? 
 
 
Daily 
 
At least 1x per week 
At least 1x per month 
Less than 1x per month 
Never 
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* 2. What are your reasons for NOT using shockwave therapy on horses in your practice? (Select all that 
apply.) 
 
My clients do not have the financial resources for shockwave therapy 
 
I do not have enough equine business to support technology such as shockwave 
There is a lack of scientific evidence showing the efficacy of shockwave 
My clinical experience is that there is a lack of treatment efficacy 
I believe the risks of the therapy outweigh the benefits 
I am not comfortable using the technology 
 
I do not know enough about the technology and therapy to recommend it as a treatment 
I do not have access to the technology 
I do not think this technology is useful in veterinary medicine 
Other (please specify) 
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* 3. Which type of shockwave therapy do you use in your practice? (Select all that apply.) 
 
VersaTron® by PulseVet® 
Shockvet® Shockwave Systems 
NEOvet® 
Storz Duolith® Vet 
 
Storz Masterpuls® MP50 Elite 
Storz Masterpuls® MP100 Elite 
Storz Masterpuls® MP200 Elite 
Storz D-Actor 
PeizoVet 100 by Wolf 
EMS Dolorclast® 
Unsure of brand of machine 
Other (please specify) 
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* 4. What type of problems do you typically treat using shockwave therapy? (Select all that apply.) 
 
Osteoarthritis; for example, in the distal hock joints 
 
Tendon injuries; for example, a bowed superficial digital flexor tendon 
Ligamentous injuries; for example, proximal suspensory desmitis in a forelimb 
Navicular syndrome 
Muscle pain; for example, lumbar epaxial muscle pain 
 
I only use shockwave therapy on client request (for various conditions) 
Other (please specify) 
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* 5. What percent (%) of time do you use shockwave therapy as a stand alone treatment? E.g.; using 
shockwave therapy only for tendon injuries, instead of combining the treatment with platelet rich plasma. 
(Enter a % out of 100.) 
 
 
 
* 6. What percent (%) of the time do you use shockwave therapy as part of a multi-modal approach? E.g.; 
combining locally-applied shockwave therapy with systemic hyaluronic acid treatment for osteoarthritis. 
(Enter a % out of 100.) 
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The following five questions will characterize your use of shockwave therapy as part of a multi-modal approach when treating various 
conditions in a horse. Please select all answers that apply. 
 
* 7. When treating osteoarthritis, I generally combine shockwave therapy with these other treatments: (select 
all that apply) 
 
Intra-articular steroids 
 
Intra-articular hyaluronic acid 
Systemic hyaluronic acid 
Systemic anti-inflammatories 
I do not generally treat osteoarthritis with shockwave therapy 
Other (please specify) 
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* 8. When treating tendon or ligament injuries, I generally combine shockwave therapy with these other 
treatments: (select all that apply) 
 
Stall rest, hydrotherapy, and hand walking 
Intra-lesional PRP 
Intra-lesional stem cell therapy 
Blistering 
I do not generally treat tendon or ligament injuries with shockwave therapy 
Other (please specify) 
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* 9. When treating navicular syndrome, I generally combine shockwave therapy with these other treatments: 
(select all that apply) 
 
Therapeutic farrier work 
Intra-articular steroids 
Bisphosphonates (Tildren, OsPhos) 
Systemic anti-inflammatories 
I do not generally treat navicular syndrome with shockwave therapy 
Other (please specify) 
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* 10. When treating muscle pain, I generally combine shockwave therapy with these other treatments: (select 
all that apply) 
 
Muscle relaxants such as methocarbamol 
Systemic anti-inflammatories 
Massage therapy 
 
Acupuncture or other complementary practices 
Heat 
Specific training or physical therapy recommendations 
 
I do not generally treat muscle pain with shockwave therapy 
Other (please specify) 
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* 11. Which further characterizes your use of shockwave therapy as part of a multi-modal treatment 
approach? (Select all that apply.) 
 
I prefer to use shockwave therapy in conjunction with other medically appropriate therapies, depending on the injury 
Shockwave therapy is never my first treatment recommendation 
I prefer to use shockwave therapy in situations where more advanced therapies are not financially possible 
I prefer to use shockwave therapy after other treatments have been pursued, i.e.: in a rehabilitation setting 
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* 12. Do you sedate every horse on which you perform shockwave therapy? 
 
Yes 
No 
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* 13. What percent (%) of horses do you perform shockwave therapy on WITHOUT sedation? (Enter a % out 
of 100.) 
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* 14. When using shockwave therapy, what percent (%) of time do you follow the protocols that were 
provided from the manufacturer of the machine? (Enter a % out of 100.) 
 
 
 
* 15. When using shockwave therapy to treat navicular syndrome, how do you apply the trode? (Select only 
one answer.) 
 
Always at the bottom of the foot, i.e.: through the frog with the foot picked up 
 
Always at the caudal aspect of the foot, i.e.: through the heel bulbs while the horse is weight-bearing 
My method of trode application varies depending on the particular case 
I do not use shockwave therapy to treat navicular syndrome 
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The following two questions focus on your opinion of the efficacy and tolerability of shockwave therapy. 
 
* 16. On a scale of 1 - 5 (1 = completely ineffective and 5 = highly effective), how effective is shockwave as 
a stand alone treatment modality for: 
 
 
 
Osteoarthritis pain 
management 
 
Tendon injuries 
Ligament injuries 
Navicular syndrome 
Muscle pain 
management 
1 (completely 
ineffective) 2 3 4 5 (highly effective) 
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* 17. On a scale of 1 - 4 (1 = intolerable and 4 = complete tolerance; N/A if no experience), on average how 
tolerant of the therapy are patients who receive shockwave to these body regions: 
 
 
 
Joints of the distal limb 
(pastern, fetlock etc.) 
 
Flexor tendons 
Foot/heels 
Hocks 
Epaxial muscles 
Other (please specify) 
1 (intolerable) 2 3 
4 (complete 
tolerance) N/A 
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The following four questions focus on the type of practice that you work in. 
 
* 18. What percent (%) of your practice is devoted to horses? (Enter a % out of 100.) 
 
 
 
 
* 19. What type of practice do you work in? (Select only one option.) 
 
Mixed practice 
 
Ambulatory practice - equine only 
Referral practice - equine only 
Referral practice - radiology 
Racetrack/horse show practice - equine only 
Reproductive focused practice 
Other (please specify) 
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* 20. What type of horses do you typically see in your practice? (Select all that apply.) 
 
All of the below  
English Performance 
Western Performance 
Rodeo horses 
Halter show horses 
 
Racehorses - Thoroughbred/QH 
Racehorses - Standardbred 
Companion/pleasure horses 
Breeding stock 
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* 21. What types of complementary or alternative veterinary medicine are offered at and used in your 
practice? (Select all that apply.) 
 
My practice does not offer complementary or alternative veterinary medicine 
Acupuncture 
Massage therapy 
Chiropractic 
Prolo therapy 
Therapeutic laser 
Therapeutic ultrasound 
Other (please specify) 
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* 22. Can I contact you with further questions after the survey is complete? 
 
Yes 
No 
 
The following demographic questions are optional, and can be left blank. All personal information will be kept confidential. Please enter your 
contact information correctly if you do not mind being contacted with further questions. 
 
 
23. Address 
 
Name 
 
Company 
 
Address 
 
Address 2 
 
City/Town 
 
State/Province 
 
ZIP/Postal Code 
 
Country 
 
Email Address 
 
Phone Number 
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24. Do you have any other comments you would like to make in regard to the use of 
shockwave therapy on horses in your practice? 
 
 
 
 
 
 
25. Do you have any comments or suggestions in regard to the survey? 
 
 
 
 
 
Thank you for your time and input on this survey! 
 
 
Do not hesitate to contact Angela MacKay at angela.mackay@usask.ca if you have any questions or comments regarding 
this survey. 
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APPENDIX B  
 
Graphical representation of kinematic gait analysis variables over time for unilateral horses only 
(Chapter 5). 
 
Figure B.1 Straight line vector sum (VS) over time, separated by group (unilateral horses only) 
 
 
 
Figure B.2 Straight line Hmin over time, separated by group (unilateral horses only) 
 
 
0
50
10
0
15
0
Ve
cto
r S
um
 A
bs
olu
te
 V
alu
e 
(m
m
)
day 0 day 14 day 28 day 128
Time
control treatment control treatment control treatment control treatment
0
50
10
0
15
0
Hm
in 
Ab
so
lut
e 
Va
lue
 (m
m
)
day 0 day 14 day 28 day 128
Time
control treatment control treatment control treatment control treatment
 141 
Figure B.3 Straight line Hmax over time, separated by group (unilateral horses only) 
 
 
 
Figure B.4 Left circle VS over time, separated by group (unilateral horses only) 
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Figure B.5 Left circle Hmin over time, separated by group (unilateral horses only) 
 
 
 
Figure B.6 Left circle Hmax over time, separated by group (unilateral horses only) 
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Figure B.7 Right circle VS over time, separated by group (unilateral horses only) 
 
 
 
Figure B.8 Right circle Hmin over time, separated by group (unilateral horses only) 
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Figure B.9 Right circle Hmax over time, separated by group (unilateral horses only). 
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